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Abstract
YIJUAN HU: Statistical Analysis of Haplotypes, Untyped SNPs, and
CNVs in Genome-Wide Association Studies.
(Under the direction of Dr. Danyu Lin.)
Missing data arise in genetic association studies when one is interested in assessing
the eects of haplotypes, untyped single nucleotide polymorphisms (SNPs) or copy
number variants (CNVs). Haplotypes are combinations of nucleotides at multiple loci
along individual homologous chromosomes, and the use of haplotypes tends to yield
more ecient analysis of disease association than SNPs. Untyped SNPs are SNPs that
are not on the genotyping chips used in the study (i.e., missing on all study subjects),
and the analysis of untyped SNPs can facilitate localization of disease-causing variants
and permit meta-analysis of association studies with dierent genotyping platforms. A
CNV refers to the duplication or deletion of a segment of DNA sequence compared to
a reference genome assembly, and can play a causal role in genetic diseases.
In the rst part of the proposal, we provide a general likelihood-based framework for
making inference on the eects of haplotypes or untyped SNPs and their interactions
with environmental variables. Unlike most of the existing methods, we allow genetic
and environmental variables to be correlated. We show that the maximum likelihood
estimators are consistent, asymptotically normal, and asymptotically ecient and we
develop EM algorithms to implement the corresponding inference procedures. We con-
duct extensive simulation studies and apply the methods to a genome-wide association
study (GWAS) of lung cancer.
In the second part, we focus on comparing two approaches in the analysis of untyped
SNPs. The maximum likelihood approach integrates prediction of untyped genotypes
iii
and estimation of association parameters into a single framework and yields consis-
tent and ecient estimators of genetic eects and gene-environment interactions with
proper variance estimators. The imputation approach is a two-stage strategy which
rst imputes the untyped genotypes by either the most likely genotypes or the ex-
pected genotype counts and then uses the imputed values in downstream association
analysis. We conduct extensive simulation studies to compare the bias, type I error,
power, and condence interval coverage between the two methods under various situa-
tions. In addition, we provide an illustration with genome-wide data from the Wellcome
Trust Case-Control Consortium (WTCCC).
In the third part, we present a general framework for the integrated analysis of
CNVs and SNPs in association studies, including the analysis of total copy number as
a special case. We use allele-specic copy numbers (ASCNs) to describe both the copy
number and allelic variations of a locus. Our approach combines the ASCN calling and
association analysis into a single step while allowing for dierential errors. We construct
likelihood functions that properly account for the case-control sampling and measure-
ment errors. We establish the asymptotic properties of the maximum likelihood estima-
tors and develop EM algorithms to implement the proposed inference procedures. The
advantages of the proposed methods over the existing ones are demonstrated through
realistic simulation studies and an application to a GWAS of schizophrenia.
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Chapter 1
Introduction
Many diseases of utmost public health signicance, including cancer, hypertension,
diabetes, and schizophrenia, are inuenced by a variety of genetic and environmental
factors, as well as gene-environment interactions. It is widely recognized that genetic
dissection of such complex human diseases requires large-scale association studies, which
relate disease phenotypes to genetic variants such as single nucleotide polymorphisms
(SNPs) and copy number variants (CNVs). In fact, there is now a proliferation of
genetic association studies worldwide thanks to the availabilities of dense SNP maps
across the human genome and precipitous drops in genotyping costs. An increasing
number of these studies survey the entire genome with high-density genotyping chips
containing hundred thousand or more SNPs for thousands of individuals; such studies
are referred to as genome-wide association studies (GWAS).
There are several options in designing population-based genetic association studies.
The simplest is the cross-sectional design, which is preferable if the disease of interest is
common or if one is interested in some disease-related traits, such as blood pressure. For
rare diseases, it is more cost-eective to adopt the case-control design, which collects
genetic and exposure information on each subject retrospectively; as a matter of fact,
owing to the strong negative selection and thereby rarity of many complex diseases,
most of ongoing studies are case-control. If one is interested in the age at onset of a
disease, then it is desirable to follow a cohort of at-risk individuals.
Missing data present a major challenge in genetic association studies. Specically,
missing data arise when one is interested in assessing the eects of haplotypes, untyped
SNPs or CNVs on disease phenotypes. The new features of such genetic variants
call for the development of novel statistical methods. In addition, the unprecedented
scale of GWAS entails new challenges. First, as the enormous number of variants
leads to serious multiple comparison problems, it is crucial to develop tests that are
optimally powered for the true associations to reach the stringent threshold of statistical
signicance. Second, the computational burden of GWAS requires methods that can
be implemented in computationally ecient algorithms.
The dissertation is organized as follows. In the rest of this chapter, we review
the existing literature and identify unresolved problems. In Chapter 2, we provide
a general framework for studying the eects of haplotypes or untyped SNPs and/or
their interactions with environmental factors. In particular, we relax the assumption of
gene-environment independence. In Chapter 3, we focus on comparing two approaches
to studying the eects of untyped SNPs, maximum likelihood and single imputation.
In Chapter 4, we present a likelihood-based framework for integrated analysis of CNVs
and SNPs in association studies, including the analysis of total copy numbers as a
special case. In Chapter 5, we outline some ongoing and future work.
1.1 Inference on Haplotype Eects
A haplotype is a specic sequence of nucleotides on the same chromosome of a subject.
Because haplotypes incorporate the linkage disequilibrium (LD) information (i.e., cor-
relation structure) of multiple SNPs and correspond to protein sequences, the use of
haplotypes tends to yield more ecient analysis of disease association than the use of
individual SNPs, especially when the causal variants are not directly measured or when
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there are strong interactions among multiple mutations on the same chromosome (Akey
et al., 2001; Fallin et al., 2001; Li, 2001; Morris and Kaplan, 2002; Schaid et al., 2002;
Zaykin et al., 2002; Schaid, 2004). Unfortunately, current genotyping technologies do
not separate a subject's two homologous chromosomes, so that we can only observe the
combination of the two haplotypes, which is referred to as the (unphased) genotype.
Many papers have focused on inferring haplotypes or estimating haplotype frequen-
cies from unphased genotype data alone, regardless of the phenotype. Excoer and
Slatkin (1995) proposed maximum-likelihood estimation of haplotype frequencies via
the expectation-maximization (EM) algorithm. Their model for haplotype frequencies
makes no assumption about the LD structure among multiple loci. Their method can
only be applied to a small number of markers at a time, because the haplotype fre-
quencies become too low to be estimated with any accuracy when more than a handful
of markers are considered. Stephens et al. (2001) developed a Bayesian approach to
inferring haplotypes via a Markov chain-Monte Carlo (MCMC) algorithm. They made
explicit assumptions about the LD patterns, exploiting ideas from population genetics
and coalescent theory. Their method can cope with a large number of linked SNPs
simultaneously, but the running time will increase greatly as the number of SNPs in-
creases. Given the probabilistically inferred haplotypes by Excoer and Slatkin (1995)
or Stephens et al. (2001), one can then relate them to the phenotype through a regres-
sion model in the downstream association analysis (e.g., Zaykin et al., 2002; Kraft et al.,
2005; Cordell, 2006). This two-stage strategy is a form of imputation, and has several
potential problems. Lin and Huang (2007) discussed in the context of case-control stud-
ies that the haplotype phasing algorithms do not acknowledge the selective-sampling
feature of the case-control design and do not take into account the phenotype. Kraft
et al. (2005) also noted that the variance estimators do not account for the uncertainty
of haplotype phasing. As a result, this imputation strategy can yield substantial bias
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of estimated genetic eects, poor coverage of condence intervals, signicant ination
of type I error and diminished power of risk haplotype detection (Kraft et al., 2005;
Cordell, 2006; Lin and Huang, 2007).
A large number of papers have been published in genetic journals on how to make
proper inference about the eects of haplotypes on disease phenotypes. Virtually all of
these methods pertain to likelihood and most of them deal with case-control studies, so
we rst make a distinction between the prospective and retrospective likelihoods. For
case-control studies, in which the sampling is conditional on the case-control status, it
is appropriate to use the retrospective likelihood. Although Prentice and Pyke (1979)
established the equivalence of the retrospective and prospective likelihoods in making
inference on the odds ratios, the equivalence requires the distribution of the covariates
to be unrestricted and does not hold when the covariate of interest is the haplotype pair
(diplotype), the distribution of which has to be restricted for the sake of identiability.
In light of this, the method of Zhao et al. (2003), which uses an estimating function
approximating the expectation of the complete-data prospective-likelihood score func-
tion given the observable data, is not statistically ecient, compared to the method of
Epstein and Satten (2003), which is based on a proper retrospective likelihood. Indeed,
Satten and Epstein (2004) compared the methods of Zhao et al. (2003) and Epstein
and Satten (2003) via simulation studies and concluded that the retrospective-likelihood
method has increased eciency with respect to the prospective method. However, Ep-
stein and Satten (2003) did not allow environmental factors as Zhao et al. (2003) did.
Stram et al. (2003) described an approach based on the joint likelihood of disease and
genotype data, after accounting for the ascertainment scheme of the case-control design.
This approach requires the sampling probabilities of cases and controls to be known
and does not allow environmental factors either. Spinka et al. (2005) accommodated
environmental factors in the proposed retrospective maximum-likelihood method and
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showed that the method is equivalent to an extension of the method by Stram et al.
(2003), which can incorporate environmental factors. Meanwhile, Schaid et al. (2002)
and Lake et al. (2003) discussed likelihood-based inference for cross-sectional studies
under generalized linear models. Lin (2004) showed how to perform the Cox (1972) re-
gression when potentially censored age-at-onset of the disease observations are collected
in cohort studies. In a general framework, Lin and Zeng (2006) provided appropriate
likelihoods for all commonly used study designs (i.e., cross-sectional, case-control and
cohort) and a variety of disease phenotypes (i.e., quantitative traits, disease indicators
and potentially censored age-at-onset). The eects of haplotypes on the phenotype are
formulated through exible regression models, which can accommodate various genetic
mechanisms and gene-environment interactions. Later, Zeng et al. (2006) extended the
framework of Lin and Zeng (2006) to case-cohort and nested case-control designs.
To be specic, we outline the method of Lin and Zeng (2006) for case-control studies.
Let H and G denote the pair of haplotypes and the genotype for an individual based
on M biallelic SNPs. We write H = (hk; hl) if the individual's haplotypes are hk and
hl, representing the kth and lth of total K possible haplotypes in the sample. Let Y
be the disease status, and let X be the environmental factors. The conditional density
of Y given (H = (hk; hl);X), denoted by P;(Y jH = (hk; hl);X), can be formulated
by the logistic regression with linear predictor,  + TZ(H = (hk; hl);X), or more
specically,
 + 1fI(hk = h) + I(hl = h)g+ T2X+ T3 fI(hk = h) + I(hl = h)gX;
where h is the target haplotype of interest. Note that an additive genetic eect and a
gene-environment interaction are assumed in the example above, although any genetic
mechanisms can be similarly formulated. Write k = P (h = hk). Lin and Zeng
(2006) demonstrated that it is generally impossible to make inference about haplotype
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eects without imposing any structure on P
 
H = (hk; hl)

. Thus they considered the
assumption of Hardy-Weinberg equilibrium (HWE), in which case
P
 
H = (hk; hl)

= kl;
and two specic forms of departure from HWE,
P
 
H = (hk; hl)

= (1  )kl + klk;
and
P
 
H = (hk; hl)

=
(1  + kl)kl
1  + PKj=1 2j ;
where kk = 1 and kl = 0 (k 6= l). Denote  = (1; : : : ; K) under HWE or  =
(; 1; : : : ; K) under the two forms of Hardy-Weinbery Disequilibrium (HWD). Lin
and Zeng (2006) allowed the distribution function of X to be fully nonparametric,
denoted as F (x); let f(x) be the corresponding density. When the disease is rare,
considerable simplicity arises because of the approximation P;(Y jH;X)  exp

Y
 
+
TZ(H;X)	. Lin and Zeng (2006) additionally assumed that X is independent of H,
so the retrospective likelihood based on (Gi;Xi; Yi), i = 1; : : : ; n, can be approximated
by
L(; F ) =
nY
i=1
P
(hk;hl)2S(Gi) e
Yi
TZ(H;Xi)P(hk; hl)f(Xi)R
x
P
(hk;hl)
eYi
TZ(H;x)P(hk; hl)dF (x)
;
where n is the number of study subjects,  = (;), and S(G) denotes the set of
diplotypes that are consistent with genotype G. Note that missing genotype values can
be incorporated by expanding the set S(G) accordingly. Lin and Zeng (2006) adopted
the nonparametric maximum likelihood estimation (NPMLE) approach, in which F (:)
is treated as a right-continuous function with jumps at the observed X. The objective
function to be maximized is obtained from L(; F ) by replacing f(x) with the jump
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size of F (:) at x. In this case, the prole likelihood, derived by maximizing L(; F )
with respect to the jump sizes of F (:) for xed values of , has a closed form
L(;) =
nY
i=1
P
(hk;hl)2S(Gi) e
Yi

+TZ(H;Xi)
	
P(hk; hl)R
y=0;1
P
(hk;hl)
eYi

+TZ(H;x)
	
P(hk; hl)
;
where  is an unknown constant and should be treated as a free parameter. Lin
and Zeng (2006) carried out the maximization by the Newton-Raphson algorithm,
and established the identiability of the parameters and the consistency, asymptotic
normality, and eciency of the maximum likelihood estimators (MLE).
All the aforementioned work assumes HWE (or certain 1-parameter extensions)
and independence of genetic and environmental factors (or absence of environmental
factors). The assumption of gene-environment independence fails in many applications.
For example, certain genes may inuence both environmental exposure and disease
occurrence. Violation of the independence assumption can cause serious bias in the
analysis (e.g., Spinka et al., 2005).
Recently, Chen et al. (2008) relaxed the assumption of gene-environment indepen-
dence by postulating a polytomous logistic regression model for the distribution of the
haplotypes conditional on the environmental factors. Specically, they assumed
log
(
P
 
H = (hk; hl)jX

P
 
H = (hK ; hK)jX
) = 0;k;l + 1;k;lX;
where H = (hK ; hK) is chosen as the reference diplotype. For the purpose of identi-
ability, they imposed further constraints on 0 and 1, which are vectorized forms for
the parameters 0;k;l and 1;k;l. Because the odds ratio associated with the distributions
P (XjH) and P (HjX) are the same, 1 can be interpreted as measures of diplotype
eects on the distribution of X. Thus it is natural to specify 1 according to certain
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model of eects of the underlying haplotypes. For example, assuming an additive eect
for the haplotypes, one can write 1;k;l = 1;k+1;l, which allows the diplotype eects to
be determined by a reduced set of haplotype eect parameters 1;k. Note that 0 denes
the diplotype frequencies for a baseline value of X. It is common to use population ge-
netics models, such as HWE, to specify a relationship between diplotype and haplotype
frequencies. However, if the diplotypes can inuence certain environmental factors, the
frequencies of the diplotypes within X categories may not follow HWE although the
underlying population, as a whole, may be in HWE. Thus, the parameter 0 can be
dened to entail that the marginal diplotype frequencies follow HWE. Denoting the
marginal haplotype frequencies by  = (1; : : : ; K), HWE means that
P
 
H = (hk; hl)

= kl:
Thus, 0 is dened as an implicit function of 1,  and F (X), denoted as 	(1;; F ),
through the relationship
kl =
Z
X
P (HjX; 0; 1)dF (X);
where F (:) is treated nonparametrically. To make inference, Chen et al. (2008) rst
derived the prole log-likelihood by proling F (:) out of the complete-data likelihood
which assumes that the underlying haplotype information is known, and then replaced
0 by 	(1;; eF ), where eF is the empirical distribution of X. After the substitution,
they obtained the complete-data estimating equation for (; 1;). Then they incor-
porated the uncertainty of the phase information by constructing a weighted version of
the complete-data estimating equation, which is solved by an EM-like algorithm. Using
their method, Chen et al. (2008) were able to detect an interaction between smoking
and a NAT2 haplotype in the development of colorectal adenoma that was undetected
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under the assumption of gene-environment independence.
Chen et al. (2008) decomposed the joint density function P (X; H) as P (HjX)P (X).
Given that genetic susceptibility may inuence environmental exposures and not vice
versa, for causal interpretation of parameters it is more natural to consider a model
for X given H. Chen et al. (2008) assumed HWE in the general population. Because
P (HjX) generally does not follow HWE when P (H) is in HWE, Chen et al. (2008) de-
ned the intercepts in their polytomous logistic model for P (HjX) as implicit functions
of all other parameters so as to impose HWE on P (H). Those constraints complicate
the estimation process. In addition, the estimating equations of Chen et al. (2008) are
not likelihood score equations, the convergence properties of their EM-like algorithms
are unclear and their estimators are not asymptotically ecient. As last, their work is
conned to case-control studies.
1.2 Inference on Untyped SNP Eects
Untyped SNPs are SNPs that are not on the genotyping chip used in the study and
are thus missing on all study subjects. Because current genotyping platforms assay
only a small fraction of SNPs in the human genome, many disease-susceptibility loci
will inevitably be untyped. Conducting association analysis at untyped SNPs is highly
desirable because it can facilitate the selection of SNPs to be genotyped in follow-up
studies and enable investigators to compare or combine results from multiple studies
with dierent genotyping chips. Indeed, this analysis has been successful in nding
associations that would not have been found using only the original genotypes. For
example, Zeggini et al. (2008) imputed 2.20 million HapMap SNPs (Altshuler, 2005)
in three studies of type 2 diabetes. Two of the studies had been genotyped on the
Aymetrix 500K GeneChip, while the third had been genotyped on the Illumina 317K
chip. The imputation of untyped SNPs resulted in two signicant results that would not
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have been found using only the original genotypes. One of these was a known association
with PPARG, while the second was a novel association with CDC123-CAMK1D, which
has been conrmed through genotyping in replication samples. These associations are
not among the top hits in any one study, but show a trend in each component study.
Because untyped SNPs are not measured on any study subject, the missing infor-
mation cannot be recovered from the study data alone. Fortunately, the LD structure
observed in an external reference panel can be used to predict untyped SNPs from
typed ones. The most common reference is the HapMap, because of the dense level of
genotyping, including over 3.1 million SNPs, on these samples. Once a reference panel
is chosen, \untyped SNPs" are often redened to be SNPs that are not genotyped in
the study sample, but are characterized in the reference panel.
The analysis of untyped SNPs is closely related to the concept of \tagging". Specif-
ically, Carlson et al. (2004) selected a single tag SNP as a proxy for every untyped
SNP such that the correlation coecient r2 between the two SNPs in the reference set
is higher than a certain threshold. de Bakker et al. (2005) proposed a multimarker
method, acknowledging the fact that some groups of SNPs as a whole work better to
predict the untyped SNP than does any single SNP. They selected a specic haplotype
to serve as a proxy by r2 criteria and compared the frequency of that haplotype be-
tween the cases and the controls. Their method results in a 1 d.f. 2 test. Although
multimarker methods are a considerable advancement, de Bakker's method does not
fully take advantage of the correlation structure between SNPs and their multimarker
tags by ignoring the additional information given by the other haplotypes other than
the proxy haplotype. Zaitlen et al. (2007) proposed a new criteria r2h for tag SNP
selection that measures the LD between a weighted combination of all haplotypes and
the untyped SNP. The weights are chosen to maximize r2h. Zaitlen et al. (2007) also
proposed a new test statistic that computes a weighted sum of all haplotype frequency
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dierences between the cases and controls. Their method is similar to that of Stram
(2004), but they did not restrict the tag SNP selection within regions of haplotype
blocks as Stram (2004) did. Their method is also similar to that of Nicolae (2006), but
they formulated a much broader set of tests than Nicolae (2006) by choosing dierent
weights, which encompasses the previous single-marker and multimarker approaches
involving one haplotype. Nevertheless, the three criteria, Zaitlen's r2h, Stram's R
2
s and
Nicolae's MD, are equivalent. All the aforementioned methods, although simple and
intuitive, are not statistically ecient and are conned to case-control comparisons
without environmental factors. In a similar spirit of tagging, Lin et al. (2008) proposed
a likelihood-based method for the analysis of untyped SNPs in case-control studies
with or without environmental factors. The likelihood integrates the study and refer-
ence data while reecting the biased nature of the case-control sampling. This method
yields consistent and ecient estimators of genetic eects and gene-environment inter-
actions, and the variance estimators fully account for the uncertainty in inferring the
unknown variants.
In what follows, we outline the method of Lin et al. (2008). First, the LD information
from a reference panel is used to select a set of (M   1) typed SNPs that provide the
most accurate prediction of the untyped SNP, where M is a small number, which
is set to ve here. The accuracy of prediction is measured by R2s of Stram (2004).
Given H and G dened on the set of M SNPs, with one of the component in G
always missing at the untyped locus, Lin et al. (2008) extended the framework of Lin
and Zeng (2006) from the analysis of haplotypes to untyped SNPs. Specically, the
conditional density P;(Y jH;X) is formulated by the logistic regression with linear
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predictor + TZ(H;X), and Z(H;X) now models the untyped SNP eects or SNP-
environment interactions. For example, under additive mode of inheritance with gene-
environment interaction,
TZ(H;X) = 1Gu(H) + T2X+ T3 Gu(H)X;
where Gu(H) denotes the genotype induced by the diplotype H at the untyped locus.
Under the assumptions of rare disease, HWE and gene-environment independence, the
likelihood for (;; F ) for the n study subjects takes the form
nY
i=1
P
(hk;hl)2S(Gi) e
Yi
TZ(H;Xi)klf(Xi)R
x
P
(hk;hl)
eYi
TZ(H;x)kldF (x)
:
Lin et al. (2008) used the prole-likelihood arguments of Lin and Zeng (2006) to elim-
inate the distribution of X, so the MLE of  and  can be equivalently obtained by
maximizing the prole likelihood
LS() =
nY
i=1
P
(hk;hl)2S(Gi) e
Yi

+TZ(H;Xi)
	
klP
y=0;1
P
(hk;hl)
ey

+TZ(H;Xi)
	
kl
;
where  = (;;) and  is an unknown constant. If there are no environmental
factors, the likelihood is simply
LS() =
nY
i=1
P
(hk;hl)2S(Gi) e
Yi
TZ(H)klP
(hk;hl)
eYi
TZ(H)kl
:
Unlike Lin and Zeng (2006), the likelihood for study subjects alone does not contain
any information about  because  will be factored out of the likelihood when the
values of the variant of interest are completely missing. Fortunately, the likelihood of
the reference panel, denoted as LR(), can be used. It is natural to assume that the
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study and reference panel are generated from the same underlying population, so the
haplotype frequencies in the reference panel can be denoted by the same parameter .
Lin et al. (2008) maximized the combined likelihood LC() = LS()LR() through the
EM algorithm. The resulting MLE is statistically ecient in that it has the smallest
variance among all valid estimators and the corresponding test of association is the most
powerful among all valid tests based on the same data and same assumptions. Indeed,
Lin et al. (2008) showed through simulation studies that their method is uniformly
more powerful than that of Nicolae (2006).
It is worth noting that the tagging-based methods, such as the method of Lin, Hu
and Huang (2008), can only be applied to a small number of tags at a time, because
the haplotype frequencies become too low to be estimated with good accuracy when
more than a handful of tags are considered. Also note that there is no mediating model
for the LD structure of the haplotypes, but the haplotype frequencies are estimated
directly (nonparametrically).
Recently, gaining popularity are a group of imputation methods which take advan-
tage of Hidden Markov Models (HMMs) (Scheet and Stephens, 2006; Marchini et al.,
2007; Li et al., 2010; Browning and Browning, 2007, 2009). As opposed to the aforemen-
tioned tagging-based methods, these HMM-based methods exploit population-genetic
theory for the LD structure and use information from all markers in LD with the un-
typed SNP. They are based on variants of the \product of approximate conditionals"
(PAC) models described in Li and Stephens (2003). In these models, a subset of hap-
lotypes comprising all SNPs on one chromosome is selected as a reference set, and each
reference haplotype represents a hidden state of the HMM at each marker. The true
haplotypes underlying the observed genotype data are assumed to be imperfect mosaics
of the reference haplotypes. Points of change from one reference haplotype to another
allow for historical recombination. The observed alleles may dier from the alleles on
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the underlying true haplotypes to allow for historical mutations and genotype errors.
As part of the model tting process, parameters such as historical recombination rates
between adjacent markers, and mutation rates may be estimated. Once the haplotypes
are inferred, the untyped genotypes can be imputed. The imputed values are then be
used as known quantities in downstream association analysis.
Like the imputation methods for haplotype analysis, the imputation approach for
untyped SNPs is, statistically speaking, less satisfactory than maximum likelihood
methods such as that of Lin et al. (2008) because of its bias and ineciency (Lit-
tle, 1992). Imputing missing data for cases and controls together can lead to a bias
toward the null hypothesis of no association and therefore a loss of power, whereas
imputing missing genotypes for cases and controls separately can inate type I error
rates (Balding, 2006; Lin and Huang, 2007). The HMM-based imputation methods
tend to extract more LD information from the typed SNPs than maximum likelihood,
and there is likely a strong relationship between the amount of information for the
untyped SNP and the performance of the association test. However, it is not guaran-
teed that more information leads to more powerful tests as the imputation approach
often uses the information ineciently. Nevertheless, imputation has several practi-
cal advantages over maximum likelihood. First, once the missing data are imputed,
the association analysis can be readily carried out for any traits and study designs
in standard software packages. Second, for each additional dataset included, it is not
necessary to conduct imputation again for existing datasets. Third, analyses regarding
secondary and tertiary phenotypes do not require specic imputation. Given the opera-
tional convenience of imputation and the statistical optimality of maximum likelihood,
comprehensive comparisons of these two approaches are sorely needed.
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1.3 Inference on Joint Eects of CNVs and SNPs
A single nucleotide polymorphism (SNP) is a DNA sequence variation that occurs when
a single nucleotide in the DNA sequence is altered. SNPs account for a majority of
human genetic variation and have been shown to have a signicant impact on disease
susceptibility. A copy number variant (CNV) refers to the amplication or deletion of
a segment of DNA sequence compared to a reference genome assembly. Recent studies
have documented the extensive presence of CNVs in the human genome (Sebat et al.,
2004; Iafrate et al., 2004; Tuzun et al., 2005; Redon et al., 2006; Kidd et al., 2008;
McCarroll et al., 2008). Changes in copy number can have dramatic phenotypic conse-
quences by altering gene dosage, disrupting coding sequences, or perturbing long-range
gene regulation. Indeed, CNVs, in particular common copy-number polymorphisms,
have been reported to be associated with several complex disease phenotypes, includ-
ing HIV acquisition and progression (Gonzalez et al., 2005), lupus glomerulonephritis
(Aitman et al., 2006), and three systemic autoimmune diseases: systemic lupus ery-
thematosus, microscopic polyangiitis and Wegener's granulumatosis (Yang et al., 2007;
Fanciulli et al., 2007).
Because CNVs and SNPs coexist throughout the human genome and may both
contribute to phenotype variation, it is desirable to consider both types of variations
in association studies of complex human diseases, characterized by allele-specic copy
numbers (ASCNs). Ignoring CNVs during SNP genotype calling can lead to erroneous
genotypes that appear to violate Mendelian inheritance (MI) or Hardy-Weinberg equi-
librium (HWE). For this reason, SNPs in the CNV regions are typically ltered out.
In addition, CNVs and SNPs may act in concert to inuence disease phenotypes. For
example, several cancer studies have shown evidence of the joint eects of CNVs and
SNPs (e.g., Van Loo et al., 2010).
SNP genotyping arrays, such as those from Aymetrix and Illumina, hold the
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promise to study CNVs and SNPs simultaneously. SNP arrays capture ASCN informa-
tion by generating quantitative two-dimensional measurements. Specically, Aymetrix
arrays provide a pair of raw allele-specic intensities for each SNP while Illumina ar-
rays transform the pair of raw intensities to a measurement of total copy number and
a measurement of allelic contrast.
Since the underlying ASCNs are not directly observed, an intuitive approach is to
call ASCNs rst and then use the ASCN calls in downstream association analysis. Var-
ious calling algorithms have been proposed to dissect copy number states from SNP
genotyping arrays. For example, several methods, such as QuantiSNP (Colella et al.,
2007), PennCNV (Wang et al., 2007) and GenoCNV (Sun et al., 2009), rely on Hid-
den Markov Models (HMMs) to segment the intensity measurements along the genome.
They were designed for Illumina array data for a single sample. PennCNV assumes that
the parameters of the HMM are known. QuantiSNP imposes some common priors for
these parameters so that only a few hyper-parameters need to be estimated. GenoCNV
allows these parameters to be estimated from the data. GenoCNV directly estimate
ASCNs. PennCNV and QuantiSNP only output calls for total copy numbers, though
ASCNs can be obtained by applying appropriate thresholds for the allelic contrast mea-
surements. For the Aymetrix 6.0 array, a commonly used software is Birdsuite (Korn
et al., 2008). While assuming prior information are available for common CNVs but
not for rare ones, rare CNVs and common CNVs are handled dierently in Birdsuite.
Rare CNVs are discovered by an HMM. For common CNVs, Birdsuite makes use of
their prior knowledge, such as the locations and copy number states, and reduces the
identication of CNVs to CNV \genotyping", which is analogous to SNP genotyping.
Specicly, at each known common CNV region, a univariate Gaussian mixture model
(GMM) is used to cluster total copy number measurements across individuals and as-
sign each individual a total copy number state. At last, the ASCNs are derived at SNP
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sites by two-dimensional GMMs informed by the total copy number assignments.
After ASCN calling, the downstream association analysis can be carried out in stan-
dard software packages. This two-step strategy is a form of \imputation" in missing
data literature. This imputation approach is not optimal for two reasons. First, the
association testing may not be robust to the dierential errors between cases and con-
trols caused by dierences in DNA quality or handling; see Figure 1.1. For example,
dierential errors arise when batch eects in array processing are correlated with the
disease status. Dierential errors are prevalent and dicult to exclude, as case and
control samples can rarely be obtained in strictly comparable circumstances to ensure
identical DNA handling. In the presence of such errors, calling ASCNs with cases and
controls combined will lead to dierential misclassication and will generate excessive
false-positive ndings of association. Second, imputation per se carries serious aws
because it ignore the phenotype which may be informative about the missing data and
the association analysis does not account for the uncertainty in inferring missing data.
In general, imputation may yield biased parameter estimators and incorrect variance
estimators, which may result in inated type I error (Hu and Lin, 2010).
Barnes et al. (2008) described a likelihood-based method for association studies with
total CNVs, which accounts for dierential errors and avoids imputation. We illustrate
the method of Barnes et al. (2008) in the following. Let R denote the quantitative
copy number measurement, K the unobserved true copy number, which is an integer,
Y the phenotype and X the environmental factors. Barnes et al's method is based on
the following factorization:
P;;;;;(R; Y;KjX) = P;(RjY;K;X)P;;(Y jK;X)P(KjX);
where the three component parts are referred to as the \signal model", \phenotype
model" and \copy number model", respectively. For the signal model, R is assumed to
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be normally distributed with mean and variance depending on K as well as on (Y;X)
to allow for dierences in DNA sources and batch eects. The \signal mean" can be
modeled through the linear regression with parameters , and the \signal variance"
can be linked to the -indexed linear predictor by a logarithmic link function. The
phenotype model can be any generalized linear model (GLM), and in particular logistic
regression for case-control studies. The copy number model P(KjX) can be simplied
by assuming gene-environment independence. Then the distribution of K is assumed
to be multinomial with  denoting the frequencies. Barnes et al. (2008) maximized the
likelihood of n study subjects
nY
i=1
P;;;;;(Ri; Yi; KijXi)
by a variation of the EM algorithm, termed the ECM algorithm, and tested the null
hypothesis  = 0 by the likelihood ratio test.
The method of Barnes et al. (2008) has important limitations. First, it is conned to
the total copy number and ignores possible allelic eects. It collapses the allele-specic
copy number measurements at SNP sites into total copy number measurements, which
may lose information and reduce power. In addition, it adopts a prospective likelihood,
which may not be appropriate for case-control studies with missing data or measurement
errors.
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Figure 1.1: An example of Aymetrix intensity data at a SNP site showing dierential
errors. The data are from a GWAS of schizophrenia (Shi et al., 2009).
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Chapter 2
A General Framework for Studying
Genetic Eects and
Gene-Environment Interactions
with Missing Data
2.1 Introduction
In this chapter, we extend the work of Lin and Zeng (2006) to allow gene-environment
dependence and to handle untyped SNPs. We provide a unied framework for assess-
ing the roles of individual SNPs (including untyped SNPs) or their haplotypes in the
development of disease. The eects of genetic and environmental factors on disease phe-
notypes are formulated through exible regression models that incorporate appropriate
genetic mechanisms and gene-environment interactions. The dependence between ge-
netic and environmental factors is characterized by a class of odds-ratio functions. The
marginal distribution of environmental factors is completely unspecied, while genetic
variables may be in Hardy-Weinberg equilibrium or disequilibrium. We construct ap-
propriate likelihoods for all commonly used study designs (including cross-sectional,
case-control, and cohort designs) and a variety of disease phenotypes/traits. Unlike
the case of gene-environment independence, the likelihoods involve the (potentially
innite-dimensional) distribution of environmental variables even under cross-sectional
and cohort designs and are thus dicult to handle both theoretically and numerically.
We establish the theoretical properties of the maximum likelihood estimators by ap-
pealing to modern asymptotic techniques, and develop ecient and stable numerical
algorithms to implement the corresponding inference procedures. We evaluate the pro-
posed methods through extensive simulation studies and apply them to a major GWAS
of lung cancer (Amos et al., 2008).
2.2 Methods
2.2.1 Notation and Assumptions
We consider a set of SNPs that are in linkage disequilibrium (i.e., correlated). We may
have a direct interest in the haplotypes of these SNPs or wish to use the haplotype
distribution to infer the unknown value of one SNP from the observed values of the
other SNPs. Let H and G denote the diplotype (i.e., the pair of haplotypes on the
two homologous chromosomes) and genotype, respectively. We write H = (h; h0) if the
diplotype consists of h and h0, in which case G = h + h0. We allow the values in G to
be missing at random. Note that H cannot be determined with certainty on the basis
of G if the two constituent haplotypes dier at more than one position or if any SNP
genotype is missing.
Let Y and X denote, respectively, the phenotype of interest and the environmen-
tal factors or covariates. We allow X to include both covariates that are potentially
correlated with H and those known to be independent of H. For cross-sectional and
case-control studies, the eects of X and H on Y are characterized by the conditional
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density of Y = y given X = x and H = (h; h0), denoted by P;;(yjx; (h; h0)), where
,  and  pertain to intercept(s), regression parameters, and nuisance parameters
(e.g., variance and overdispersion parameters), respectively. The regression eects are
specied through the design vector Z(X; H), which is a vector-function of X and H.
For example, if we are interested in the additive genetic eect of a risk haplotype h
and its interactions with X, then we may specify
Z(x; (h; h0)) =
266664
I(h = h) + I(h0 = h)
x
fI(h = h) + I(h0 = h)gx
377775 ; (2:1)
where I() is the indicator function. For dominant and recessive models, we replace
I(h = h) + I(h0 = h) by I(h = h or h0 = h) and I(h = h0 = h), respectively; the
co-dominant model contains both additive and recessive eects. If we are interested in
the additive eect of a particular SNP, then we replace I(h = h) + I(h0 = h) by the
value of (h+h0) at that SNP position; dominant, recessive and co-dominant eects are
dened similarly.
Let K be the total number of haplotypes that exist in the population. For k =
1; : : : ; K, we denote the kth haplotype by hk. Dene kl = Pr(H = (hk; hl)) and
k = Pr(h = hk), k; l = 1; : : : ; K. Under HWE,
kl = kl; k; l = 1; : : : ; K: (2:2)
We also consider two forms of Hardy-Weinberg disequilibrium (HWD),
kl = (1  )kl + klk; (2:3)
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and
kl =
(1  + kl)kl
1  + PKj=1 2j ; (2:4)
where 0 < k  1,
PK
k=1 k = 1, kk = 1, and kl = 0 (k 6= l) (Lin and Zeng,
2006). Both (2.3) and (2.4) reduce to (2.2) if  = 0. Excess homozygosity (i.e.,
kk > 
2
k; k = 1; : : : ; K) and excess heterozygosity (i.e., kk < 
2
k; k = 1; : : : ; K) arise
when  > 0 and  < 0, respectively, although the range of heterozygosity is restrictive.
Denote the probability function of H by P(), where  consists of  = (1; : : : ; K)T
under (2.2) and  and  under (2.3) or (2.4).
We formulate the dependence of X on H through the conditional density function
P (XjH). Because of missing genetic data, P (XjH) cannot be completely nonparamet-
ric. Mimicking Chen (2004)'s idea, we dene the general odds-ratio function
(X;x0; H; (h0; h
0
0)) =
P (XjH)P (x0jh0; h00)
P (Xjh0; h00)P (x0jH)
;
where (h0; h
0
0) and x0 are xed points in the sample spaces of H and X, respectively.
Then
P (XjH) = (X;x0; H; (h0; h
0
0))P (Xjh0; h00)R
x
(x;x0; H; (h0; h00))P (xjh0; h00)dx
;
so the conditional density function is represented by the odds ratio function  and the
conditional density at a xed point P (Xjh0; h00). We abbreviate P (xjh0; h00) as f(x)
and denote the corresponding distribution function by F (x).
Without loss of generality, set (h0; h
0
0) = (hK ; hK). If X consists of S components
that are either continuous or dichotomous, then we may specify that
log (x;x0; (hk; hl); (hK ; hK)) =
SX
s=1
s;k;l(xs   x0;s);
where x = (x1; : : : ; xS)
T, x0 = (x0;1; : : : ; x0;S)
T, and s;k;l (s = 1; : : : ; S; k; l = 1; : : : ; K)
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are log odds ratios with s;K;K = 0. Any categorical covariate of l levels can be repre-
sented by (l 1) dichotomous variables. Specic mode of inheritance is imposed on s;k;l
(k; l = 1; : : : ; K) to ensure identiability. Under the additive model, s;k;l = s;k + s;l
with s;K = 0. If a certain component of X, indexed by s
0, is known to be indepen-
dent of H, then we set the corresponding s0;k;l (k; l = 1; : : : ; K) to 0. In general,
log (x;x0; (hk; hl); (hK ; hK)) = 
TD(x; hk; hl), where  is a set of log-odds ratio pa-
rameters, and D(x; hk; hl) is a set of distance measures. This formulation encompasses
all generalized linear models for X with canonical links to H.
REMARK 2.1 Chen et al. (2008) assumed HWE and decomposed the joint density
function P (X; H) as P (HjX)P (X). Because P (HjX) generally does not follow HWE
when P (H) is in HWE, Chen et al. (2008) dened the intercepts in their polytomous
logistic model for P (HjX) as implicit functions of all other parameters so as to impose
HWE on P (H). Those constraints complicate the estimation process. By contrast,
we decompose P (X; H) as P (XjH)P (H), so that the population genetics assumption
on P (H) can be incorporated directly and there are no constraints on other parame-
ters. The odds ratios associated with P (XjH) and P (HjX) are the same and can be
interpreted as the eects of H on X or the eects of X on H.
In the sequel, S(G) denotes the set of diplotypes that are compatible with genotype
G, hy denotes a haplotype that diers from h at only one SNP site, and ruf(u;v) =
@f(u;v)=@u. For any parameter , we use 0 to denote its true value when the dis-
tinction is necessary. We assume that the true value of any Euclidean parameter 
belongs to the interior of a known compact set within the domain of  and that F0 is
twice-continuously dierentiable with positive derivatives in its support.
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2.2.2 Cross-Sectional Studies
In a cross-sectional study, we measure the phenotype Y, genotype G and covariates X
on a random sample of n subjects, so the data consist of (Yi;Xi; Gi) (i = 1; : : : ; n).
The phenotype or trait Y can be any type (e.g., binary or continuous) and possibly
multivariate. As mentioned in Section 2.2.1, the conditional density of Y given X and
H is given by P;;(YjX; H), which can be formulated by generalized linear models
for univariate traits and by generalized linear mixed models for multivariate traits.
Write  = (;; ;; ). The likelihood for  and F is
Ln(; F ) =
nY
i=1
X
H2S(Gi)
P;;(YijXi; H)P;F (XijH)P(H); (2:5)
where
P;F (xjh; h0) = expf
TD(x; h; h0)gf(x)Rex expfTD(ex; h; h0)gdF (ex) :
We use the NPMLE approach. In this approach, the distribution function F () is
treated as a right-continuous function with jumps at the observed X. The objective
function to be maximized is obtained from (2.5) by replacing f(x) with the jump size
of F at x. The maximization can be carried out by the EM algorithm described in
Section 2.6.1.
2.2.3 Case-Control Studies
In a case-control study, we measure X and G on n1 cases (Y = 1) and n0 controls
(Y = 0). It is natural to formulate the eects of X and G on Y through the logistic
regression model
P;(Y jX; H) = expfY ( + 
TZ(X; H))g
1 + expf+ TZ(X; H)g ; (2:6)
where  is an intercept and  is a set of log odds ratios.
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Write  = (;;; ). To reect case-control sampling, we employ the retrospective
likelihood:
Ln(; F ) =
nY
i=1
P
H2S(Gi) P;(YijXi; H)P;F (XijH)P(H)R
x
P
H P;(Yijx; H)P;F (xjH)P(H)dx
: (2:7)
There is very little information about  in case-control data, so the problem is virtually
non-identiable. We focus on two tractable situations: when the disease is rare, and
when the disease rate is known. Under such conditions, the haplotype distribution of
the general population can be estimated reliably from case-control data.
Rare Disease
When the disease is rare, model (2.6) simplies to P;(Y jX; H)  exp

Y
 
 +
TZ(X; H)	: Then the likelihood given in (2.7) becomes
Ln(; F ) =
nY
i=1
(P
H2S(Gi) expfTZ(Xi; H)gP;F (XijH)P(H)R
x
P
H expfTZ(x; H)gP;F (xjH)P(H)dx
)Yi

( X
H2S(Gi)
P;F (XijH)P(H)
)1 Yi
; (2:8)
in which  consists of ,  and  only. We again adopt the NPMLE approach, which
is implemented via the EM algorithm described in Section 2.6.2.
Known Disease Rate
Let p1 be the known disease rate. We maximize the likelihood given in (2.7) or
equivalently
Ln(; F ) =
nY
i=1
X
H2S(Gi)
P;(YijXi; H)P;F (XijH)P(H)
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subject to the constraint that
R
x
P
H P;(Y = 1jx; H)P;F (xjH)P(H)dx = p1: We
show in Section 2.6.3 that the NPMLEs of  and F can be obtained via an EM algo-
rithm.
REMARK 2.2 Chen et al. (2008) also focused on the situations of rare disease and
known disease rate. Because their estimating equations are not likelihood score equa-
tions and involve constraints for the intercepts of their polytomous logistic model, the
convergence properties of their EM-like algorithm are unclear, and their estimators are
not asymptotically ecient. By contrast, our objective functions are likelihood func-
tions, which are guaranteed to increase at each step of the EM algorithms, and the
resulting estimators are asymptotically ecient.
2.2.4 Cohort Studies
In a cohort study, we follow a random sample of n at-risk subjects to observe their ages
at onset of disease. The subjects who are disease-free during the follow-up contribute
censored observations. Let Y and C denote the time to disease occurrence and the
censoring time, respectively. It is assumed that C is independent of Y andH conditional
on X and G. The data consist of (eYi;i;Xi; Gi); i = 1; : : : ; n, where eYi = min(Yi; Ci),
and i = I(Yi  Ci).
We formulate the eects of X and H on Y through a class of semiparametric trans-
formation models
(tjX; H) = Q((t)eTZ(X;H));
where (jX; H) is the cumulative hazard function of Y given X and H, () is an
unspecied increasing function, and Q() is a three-time dierentiable function with
Q(0) = 0 and Q0(x) > 0 and satisfying condition (e) of Zeng and Lin (2007). Here
and in the sequel, g0(x) = dg(x)=dx and g00(x) = d2g(x)=dx2. The choices of Q(x) = x
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and Q(x) = log(1 + x) yield the proportional hazards model (Cox, 1972) and the
proportional odds model (Bennett, 1983), respectively.
Write  = (;; ). The likelihood concerning ,  and F takes the form
Ln(;; F ) =
nY
i=1
X
H2S(Gi)
n
0(eYi)eTZ(Xi;H)Q0((eYi)eTZ(Xi;H))oi
 exp
n
 Q((eYi)eTZ(Xi;H))oP;F (XijH)P(H): (2:9)
Adopting the NPMLE approach, we regard  and F as right-continuous functions and
replace 0(eYi) and f(x) in (2.9) with the jump size of  at eYi and the jump size of F
at x. The estimation can be carried out through EM algorithms; see Section 2.6.4.
2.2.5 Asymptotic Properties
The NPMLEs in Sections 2.2.2{2.2.4, denoted by b, bF and b, are consistent, asymptot-
ically normal, and asymptotically ecient; rigorous statements and proofs are provided
in Theorems 2.1{2.4 of Section 2.6. The limiting covariance matrix of b can be consis-
tently estimated by inverting the information matrix for all parameters (including the
jump sizes of nuisance functions) or by using the prole likelihood function (Murphy
and van der Vaart, 2000).
2.2.6 Untyped SNPs
When one of the SNPs in G is untyped, i.e., missing on all study subjects, the haplotype
distribution  cannot be estimated from the study data alone. Fortunately, external
databases, such as the HapMap, can be used to estimate  provided that the external
sample and the study sample are generated from the same underlying population.
Let LR() denote the likelihood for  based on the external sample. If the external
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sample consists of en unrelated subjects, then LR() = Qenj=1P(hk;hl)2S(Gj) kl, where
Gj is the genotype of the jth subject. The HapMap database provides genotype infor-
mation for trios. For an external sample of en trios, the genotype data for the jth trio
consist of Gj  (GFj; GMj; GCj) (j = 1; : : : ; en), where GFj, GMj and GCj denote the
genotypes for the father, mother and child, respectively. Then
LR() =
enY
j=1
X
(hk;hl;hk0 ;hl0 )2S(Gj)
klk0l0 ;
where (hk; hl; hk0 ; hl0) 2 S(Gj) means that (hk; hl) is compatible with GFj, (hk0 ; hl0)
is compatible with GMj, and (hk; hk0), (hk; hl0), (hl; hk0) or (hl; hl0) is compatible with
GCj.
Denote the likelihood for the study data by LS(), in which  consists of , as well
as all other nite- and innite-dimensional parameters in the likelihood. The likelihood
for  that combines the study data and the external data is LC()  LS()LR(): We
maximize LC() in the same manner as in the maximization of LS(); the score function
and information matrix for LR() are provided in Appendix B of Lin et al. (2008).
The resulting estimators of  are consistent, asymptotically normal and asymptotically
ecient.
2.3 Simulation Studies
We conducted extensive simulation studies to assess the operating characteristics of the
proposed methods in realistic scenarios. We considered 5 SNPs (rs10519198, rs13180,
rs3743079, rs8034191 and rs3885951) in a gene on chromosome 15 that is known to
aect both smoking behaviour and lung cancer (Amos et al., 2008). Table 2.1 displays
the haplotype frequencies of the 5 SNPs. We simulated genotype data from those
haplotype frequencies under HWE.
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Our rst set of studies was concerned with the inference on haplotype eects and
haplotype-environment interactions in case-control studies. We simulated disease status
from the logistic regression model with an additive eect of h2:
logitPrfY = 1jX;H = (h; h0)g
=  + 1fI(h = h2) + I(h0 = h2)g+ 2X + 3fI(h = h2) + I(h0 = h2)gX;
whereX is Bernoulli with Pr(X = 1j(hK ; hK)) = :2. We let log (X; 0; (hk; hl); (hK ; hK)) =
(1;k + 1;l)X, where 1;2 = 0:2, 1;4 =  0:2, 1;9 = 0:1 and 1;k = 0 (k 6= 2; 4; 9).
For making inference on 1, we set 2 = :25 and 3 = :0 and varied 1 from  :5
to :5; for making inference on 3, we set 1 = 2 = :25 and varied 3 from  :5 to
:5. We chose  =  3 and  2:1 to yield disease rates between 5% and 15%. We let
n1 = n0 = 500 and adopted the rare disease assumption in the analysis. We also
included the method of Lin and Zeng (2006), which assumes haplotype-environment
independence. The results are summarized in Table 2.2.
The proposed estimator for 1 is virtually unbiased. The proposed estimator for 3
seems to be slightly biased downward when the disease rate is close to 15%. The pro-
posed variance estimators accurately reect the true variabilities, the Wald tests have
proper type I error, and the condence intervals have reasonable coverage probabilities.
The rare-disease assumption is a good approximation even when the disease rate is as
high as 15%. Under the Lin-Zeng method, the estimators are biased, the type I error
is inated, and the condence intervals have poor coverage probabilities, especially for
interactions.
To assess the eciency loss of modelling gene-environment dependence when the
independence assumption actually holds, we modied the above simulation set-up by
letting  = 0. For making inference on 1, we set  =  3, 2 = :25 and 3 = 0
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and varied e1 from 1:3 to 1:6; for making inference on 3, we set 1 = 2 = :25 and
varied e3 from 1:5 to 2:3. As shown in Figure 2.1, the power loss is more substantial
in testing interactions than in testing main eects. In practice, one should incorporate
the independence assumption into the analysis if it is known to be true. Indeed, our
formulation allows one to impose the independence on any subset of X. If the indepen-
dence is not known to hold or not, then the empirical Bayes-type shrinkage estimation
(e.g., Chen et al., 2009) provides a nice trade-o between eciency and robustness; see
Section 2.6.5.
The aforementioned studies pertain to a binary covariate and to risk haplotype h2,
which has a relatively high frequency. Additional simulation studies revealed that the
above conclusions continue to hold for other haplotype frequencies and other covariate
distributions. For example, the left panel of Table 2.3 shows the results under the
logistic regression model
logitPrfY = 1jX1; X2; (h; h0)g
=  + h2fI(h = h2) + I(h0 = h2)g+ h1fI(h = h1) + I(h0 = h1)g
+x1X1+x2X2+x1h2fI(h = h2)+I(h0 = h2)gX1+x1h1fI(h = h1)+I(h0 = h1)gX1;
coupled with the odds ratio function log ((X1; X2); (0; 0); (hk; hl); (hK ; hK)) = (1;k +
1;l)X1; where X1 and X2 are independent conditional on H, the conditional distribu-
tion of X1 given H = (hK ; hK) is standard normal, X2 is Bernoulli with :4 success
probability,  =  3, h1 = h2 = :25, x1 = x2 = :3, x1h2 = x1h1 = :0, 1;2 = 0:2,
1;4 =  0:2, 1;9 = 0:1 and 1;k = 0 (k 6= 2; 4; 9).
To assess the robustness of the proposed method, we modied the above setting to
simulate a conditional distribution of X given H that does not t into the odds ratio
formulation. Specically, we let the conditional density of X1 given H = (hk; hl) be k+
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l + t, where t follows a 3 d.f. t-distribution truncated at 5. The results are provided
in the right panel of Table 2.3. The proposed method is robust to misspecication of
the dependence structure.
We also compared the proposed method to that of Chen et al. (2008). We simulated
data from the logistic regression model
logitPrfY = 1jX;H = (h; h0)g
=  + 1fI(h = h3) + I(h0 = h3)g+ 2X + 3fI(h = h3) + I(h0 = h3)gX;
and the odds ratio function log (X; 0; (hk; hl); (hK ; hK)) = (1;k + 1;l)X, where the
conditional distribution of X given H = (hK ; hK) is standard normal, 1;3 = 0:2,
1;4 =  0:2, 1;9 = 0:1 and 1;k = 0 (k 6= 3; 4; 9). We set n1 = n0 = 500 and  =  3. For
making inference on 1, we set 2 = 0:25 and 3 = 0 and varied e
1 from 1.5 to 1.8; for
making inference on 3, we set 1 = 2 = 0:25 and varied e
3 from 1.5 to 1.8. For each
combination of simulation parameters, we generated 1,000 data sets. Our algorithm
always converged, whereas the algorithm of Chen et al. (2008), as implemented in their
SAS program, failed to converge in about 3% of the data sets. Figure 2.2 presents the
power curves of the two methods based on the data sets in which the algorithm of Chen
et al. converged. The proposed method is uniformly more powerful than Chen et al.'s,
especially in detecting interactions.
Our nal set of studies dealt with analysis of untyped SNPs in cohort studies. We
simulated ages at onset of disease from the proportional hazards model (tjX;H) =
t2e1G4(H)+2X+3G4(H)X ; where G4(H) is the genotype induced by the diplotype H at
the 4th locus, and X is the same as in the rst set of case-control studies. We gener-
ated censoring times from the uniform (0; ) distribution, where  was chosen to yield
approximately 250, 500 or 1,000 cases under n =5,000. We set 1 = 2 = :25 and
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varied 3 from  :5 to :5. We set the 4th SNP to be missing in the observed data and
generated an external data set of 30 trios from the haplotype distribution of Table 2.1.
As shown in Table 2.4, the proposed method performs very well.
2.4 Lung Cancer Study
Lung cancer is the most common type of cancer in terms of both incidence and mortality,
with the highest rates in Europe and North America. Although this malignancy is
attributable to environmental exposures, primarily cigarette smoking, genetic factors
inuencing lung cancer susceptibility have been reported in numerous studies. Recently,
a genome-wide case-control association study of histologically conrmed non-small cell
lung cancer was conducted to identify common low-penetrance alleles inuencing lung
cancer risk (Amos et al., 2008). Controls were matched to cases according to smoking
behavior, age (in 5-year groups) and sex, and former smokers were further matched by
years of cessation. The study population was restricted to individuals of self-reported
European descent to minimize confounding by ethnic variation.
In the discovery phase of the study, 1,154 ever-smoking cases and 1,137 ever-smoking
controls were genotyped for 317,498 tagging SNPs on Illumina HumanHap300 v1.1
BeadChips. Two SNPs, rs1051730 and rs8034191, mapping to a region of strong link-
age disequilibrium within 15q25.1 containing PSMA4 and the nicotinic acetylcholine
receptor subunit genes CHRNA3 and CHRNA5, were found to be signicantly associ-
ated with lung cancer risk. The investigators kindly provided us data on a cluster of
37 SNPs surrounding those two SNPs.
We rst investigate haplotype eects and haplotype-smoking interactions with slid-
ing windows of 5 SNPs. For each window, we t a logistic regression model that
compares all haplotypes (with observed frequencies greater than 0.2% in the control
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group) to the most frequent haplotype under the additive mode of inheritance and in-
cludes cigarettes per day as a continuous covariate. Because the SNPs in the region are
known to be associated with smoking behavior, we allow all haplotypes (with observed
frequencies greater than 0.4% in the control group) to be potentially correlated with
the smoking variable in the proposed general odds-ratio function. We assume HWE
and adopt the rare-disease approximation. For comparisons, we also t the haplotype-
environment independence model of Lin and Zeng (2006).
Table 2.5 presents the results for a window containing SNP rs1051730. Haplotype
11110 is signicantly related to smoking. Haplotype 00000 also has a large eect on
smoking, although not signicant at the 0.05 level. For those two haplotypes, the
Lin-Zeng method would declare statistical signicance at the 0.05 level for haplotype-
smoking interactions, whereas the proposed method would not. These dierences are
consistent with the simulation results shown in Table 2.2 that the Lin-Zeng method
tends to produce false positive results for haplotype-environment interactions when the
independence assumption fails.
Next, we investigate the eects of individual SNPs and their interactions with smok-
ing in the development of lung cancer for the 37 typed SNPs and 259 untyped HapMap
SNPs in the region. In accordance with the study sample, we choose the HapMap sam-
ple of Utah residents with ancestry from northern and western Europe as the reference
panel in the analysis of untyped SNPs. For each untyped SNP, we identify a set of
4 typed SNPs within 100,000 base pairs that provides the best prediction (Lin et al.,
2008). We apply the proposed and Lin et al. (2008) methods. The former allows gene-
environment dependence whereas the latter assumes independence. For typed SNPs,
we also perform standard logistic regression analysis, which allows any form of gene-
environment dependence and thus serves as a benchmark. The dependence between
smoking and SNPs in the region of interest turns out to be very strong; the results are
34
not shown here. Figure 2.3 displays the results for testing SNP eects (adjusted for
smoking) and for testing SNP-smoking interactions. For typed SNPs, the results based
on the proposed method and standard logistic regression are highly similar, suggesting
that our odds ratio formulation is reasonable; the results of the Lin et al. method are
dierent, especially for interactions. For untyped SNPs, the Lin et al. method yields
more signicant results, especially for interactions, than the proposed method. Because
of the strong gene-environment dependence, the results of the Lin et al. method are
unreliable.
2.5 Discussion
This chapter extends the work of Lin and Zeng (2006) to allow gene-environment de-
pendence and to handle untyped SNPs. As demonstrated in the simulation studies
and real example, the results of association analysis depend critically on the assump-
tion about gene-environment relationship. If the genetic and environmental factors
are known to be independent, then one should impose this structure in the analysis
to improve eciency. If the independence does not hold, then one should avoid this
assumption to enhance the validity of inference.
Unlike Lin and Zeng (2006), our likelihood functions involve the (potentially innite-
dimensional) distribution of covariates even for cross-sectional and cohort studies. Also,
Lin and Zeng (2006) did not consider case-control studies with known disease rates.
Even for case-control studies with rare disease, our likelihood function is more compli-
cated than that of Lin and Zeng (2006) because the distribution of covariates cannot
be proled out due to the modeling of gene-environment dependence. Thus, our nu-
merical algorithms are fundamentally dierent from those of Lin and Zeng (2006) for
all study designs. Although the basic structures of our theoretical proofs are similar
to those of Lin and Zeng (2006), the actual techniques employed are novel. Due to the
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presence of multiple nonparametric conditional distribution functions of X given H,
the proofs of identiability of parameters and nonsingularity of information matrices
are very delicate.
Lin and Zeng (2006) considered the setting in which X is independent of H condi-
tional on G. It is dicult to construct realistic scenarios in which X is independent of
H conditional on G but not independent of H unconditionally. Indeed, G is equivalent
to H if there is only a single SNP or H consists of (h; h) or (h; hy). It is more natural
to allow direct association between H and X, as is done in this chapter.
We have assumed that X is completely observed. In practice, the values of certain
environmental variables (e.g., smoking history and dietary information) may be un-
known on some study subjects. A major advantage of the odds-ratio formulation is that
it can readily handle missing covariates (Chen, 2004). Specically, we express P (XjH)
as P (X1jH)P (X2jX1; H) P (X3jX1; X2; H) : : :, and represent each conditional density
function in terms of a general odds ratio function and an arbitrary one-dimensional dis-
tribution function. In this way, we can accommodate arbitrary missing patterns in X
and easily extend the theory and numerical algorithms of this chapter.
In the genetic and epidemiologic literature, it has become a common practice to infer
the haplotypes or the values of untyped SNPs for each subject based on the genotype
data alone and then include those imputed values in downstream association analysis.
This is single imputation with improper posterior distributions and can yield biased
estimates of genetic eects, inated type I error and reduced statistical power (e.g., Lin
and Huang, 2007; Lin et al., 2008).
We infer the unknown value of an untyped SNP nonparametrically from a small
set of typed SNPs which is chosen to provide the best prediction among all anking
SNPs. An alternative approach is to use all typed SNPs on the chromosome under
a population genetics model. To incorporate the latter approach into our framework,
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we let G denote all the SNPs on the chromosome and decompose G into the typed
component Gt and the untyped component Gt. The joint density of the observed data
(Y;X; Gt) can be written as
P (Y;X; Gt) =
X
Gu
P (YjX; Gt; Gu)P (XjGt; Gu)P (Gt; Gu):
We calculate P (Gt; Gu) through a hidden Markov model (e.g., Marchini et al., 2007). It
is dicult to correctly specify the regression model P (YjX; Gt; Gu). For estimating the
marginal eect of an untyped SNP, we include only that SNP in the regression model.
Even when we are interested in the marginal eect of a single SNP, we need to include
all the SNPs on the chromosome that are correlated with X in P (XjGt; Gu). Inclusion
of a large number of SNPs is computationally infeasible and statistically inecient,
whereas omission of important SNPs can bias the association analysis. We prefer the
anking SNPs approach because it is computationally simpler and yield more robust
and possibly more ecient inference.
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Table 2.1: Observed haplotype frequencies from a lung cancer study
Index Haplotype Frequency
h1 00000 .0278
h2 00010 .2101
h3 00011 .0923
h4 01000 .2080
h5 01001 .0005
h6 01010 .0026
h7 10010 .0078
h8 10011 .0083
h9 11100 .1465
h10 11110 .0158
h11 10000 .2803
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Table 2.2: Simulation results for estimating and testing haplotype eects and
haplotype-environment interactions in case-control studies
Proposed Lin-Zeng
 1 Bias SE SEE CP Power Bias SE SEE CP Power
-2.1 -.5 .001 .138 .137 .989 .861 -.051 .131 .131 .985 .955
-.25 .000 .132 .132 .989 .250 -.049 .125 .125 .987 .433
0 .003 .129 .127 .990 .010 -.047 .121 .120 .985 .015
.25 .002 .123 .125 .993 .287 -.047 .114 .117 .988 .198
.5 .002 .122 .123 .992 .940 -.046 .114 .114 .982 .918
-3 -.5 -.001 .138 .139 .992 .863 -.052 .131 .132 .988 .951
-.25 .002 .133 .133 .988 .239 -.048 .126 .126 .985 .416
0 .003 .127 .128 .993 .007 -.048 .119 .120 .985 .015
.25 .003 .123 .124 .991 .290 -.047 .116 .116 .982 .203
.5 .000 .124 .122 .991 .941 -.050 .114 .113 .984 .916
 3
-2.1 -.5 -.003 .270 .270 .992 .243 .284 .190 .193 .842 .052
-.25 -.010 .261 .260 .989 .052 .255 .178 .178 .857 .011
0 -.004 .259 .254 .990 .010 .217 .167 .167 .891 .109
.25 -.004 .253 .251 .991 .051 .161 .158 .158 .937 .519
.5 -.017 .257 .252 .989 .250 .082 .149 .151 .981 .899
-3 -.5 -.001 .273 .270 .989 .227 .248 .194 .193 .883 .079
-.25 -.002 .256 .259 .988 .051 .238 .176 .178 .880 .009
0 -.002 .255 .251 .988 .012 .221 .164 .165 .882 .118
.25 -.003 .245 .246 .991 .052 .195 .155 .155 .901 .612
.5 -.010 .249 .243 .989 .282 .154 .148 .148 .936 .967
NOTE: Bias and SE are the bias and standard error of the parameter estimator. SEE
is the mean of the standard error estimator. CP is the coverage probability of the
99% condence interval. Power pertains to the .01-level test of zero parameter value.
Each entry is based on 5,000 replicates.
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Table 2.3: Simulation results for estimating and testing haplotype eects and
haplotype-environment interactions in case-control studies with two risk haplotypes
and two covariates
Correctly specied P (XjH) Misspecied P (XjH)
Para. True Value Bias SE SEE CP Power Bias SE SEE CP Power
h2 .25 .000 .116 .114 .992 .361 .010 .113 .114 .989 .378
h1 .25 .003 .288 .283 .990 .041 .013 .298 .287 .989 .045
x1 .3 .003 .084 .083 .991 .859 .014 .060 .059 .988 .997
x2 .3 -.005 .129 .130 .991 .377 .001 .131 .132 .989 .385
x1h2 .0 -.002 .109 .105 .987 .013 -.017 .070 .071 .989 .011
x1h1 .0 .005 .267 .269 .991 .009 -.008 .181 .182 .990 .010
NOTE: See the Note to Table 2.2.
Table 2.4: Simulation results for the analysis of an untyped SNP in cohort studies
3 Cases Bias SE SEE CP Power
0 250 -.003 .236 .233 .990 .010
500 .004 .164 .163 .992 .008
1,000 .001 .120 .120 .990 .010
-.25 250 -.003 .262 .256 .991 .049
500 .003 .180 .178 .988 .112
1,000 .001 .130 .129 .990 .254
-.5 250 -.009 .295 .285 .990 .194
500 -.000 .203 .197 .991 .491
1,000 .001 .144 .142 .989 .842
.25 250 .001 .217 .215 .991 .077
500 .003 .154 .153 .991 .177
1,000 .000 .114 .115 .992 .345
.5 250 .000 .203 .202 .991 .457
500 .002 .147 .146 .991 .813
1,000 -.003 .113 .112 .991 .973
NOTE: See the Note to Table 2.2.
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Table 2.5: Estimates of haplotype eects and haplotype-smoking interactions for a set
of 5 SNPs in the lung cancer study
Parameters Proposed Lin-Zeng
Logistic disease-risk model ()
11110 .249(.069)** .252(.069)**
11011 -.097(.084) -.099(.084)
00000 .198(.139) .201(.139)
11010 -.255(.237) -.252(.237)
00011 .519(.737) .536(.748)
smoking .093(.090) .021(.071)
11110smoking -.013(.069) .094(.047)*
11011smoking -.032(.087) -.061(.062)
00000smoking .108(.132) .190(.086)*
11010smoking -.044(.236) -.006(.181)
00011smoking .289(.349) .290(.348)
General odds-ratio function ()
11110 .108(0.050)* {
11011 -.030(.061) {
00000 .083(.100) {
11010 .038(.151) {
NOTE: Standard error estimates are shown in parentheses. *P < 0:05. **P < 0:001.
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Figure 2.1: Power of testing (a) main eects and (b) interactions at the 1% nomi-
nal signicance level for the proposed and Lin-Zeng methods when the independence
assumption holds.
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Figure 2.2: Power of testing (a) main eects and (b) interactions at the 1% nominal
signicance level for the proposed and Chen et al. methods.
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Figure 2.3: Results of association tests for additive eects of individual SNPs in the lung
cancer study: the   log10(p-values) for the genotyped and untyped SNPs are shown in
circles and dots, respectively; (a), (b) and (c) pertain to testing SNP eects (adjusted
for smoking) under the standard logistic regression, the proposed method and the Lin
et al. method, respectively; (d), (e) and (f) pertain to testing SNP-smoking interactions
under the standard logistic regression, the proposed method and the Lin et al. method,
respectively.
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2.6 Appendix
In this section, we present the EM algorithms (treating H as missing data) for all the
designs considered. We state in Theorems 2.1{2.4 the asymptotic properties of the
NPMLEs described in Sections 2.2.2{2.2.4 and provide the proofs of the theorems. For
each theorem, it is necessary to verify that the parameters are identiable and the
information matrices along all non-trivial parametric submodels are non-singular. We
state those intermediate results in Lemmas 2.1{2.8.
2.6.1 Cross-Sectional Studies
Numerical Algorithm
Suppose that there are J distinct values of X, denoted by x1; : : : ;xJ . Let Ffxjg
be the jump size of F at xj. To incorporate the restriction that
P
j Ffxjg = 1, we
estimate log(Ffxjg=FfxJg) (j = 1; : : : ; J   1) instead. Dene Djkl = D(xj; hk; hl),
Zjkl = Z(xj; hk; hl),
Wkl =
0BBBB@
I(hk = h1) + I(hl = h1)
...
I(hk = hK 1) + I(hl = hK 1)
1CCCCA ;Mjkl =
0BBBBBBB@
Djkl
I(j = 1)
...
I(j = J   1)
1CCCCCCCA
;  =
0BBBBBBB@

log(Ffx1g=FfxJg)
...
log(Ffx(J 1)g=FfxJg)
1CCCCCCCA
:
To incorporate the constraint that
P
k k = 1, we dene k = log(k=K) and  =
(1; : : : ; K 1)T, so P(H = (hk; hl)) = exp(TWkl)=
P
k;l exp(
TWkl). Under X = xj
and H = (hk; hl),
expfTD(X; H)gf(X)R
x
expfTD(x; H)gdF (x) =
exp(TMjkl)P
j0 exp(
TMj0kl)
:
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The complete-data log-likelihood is
lcn =
X
i;j;k;l
IfXi = xj; Hi = (hk; hl)g

logP;;(Yijxj; (hk; hl)) + TWkl + TMjkl
  log
X
j0
exp(TMj0kl)

  n log
X
k;l
exp(TWkl):
In the E-step, we evaluate EfI(Xi = xj; Hi = (hk; hl))
Xi;Yi; Gig, which can be shown
to be
!ijkl 
IfXi = xj ; (hk; hl) 2 S(Gi)gP;;(Yijxj ; (hk; hl))eTWkl+TMjkl=
P
j0 e
TMj0klP
(hk0 ;hl0 )2S(Gi) P;;(Yijxj ; (hk0 ; hl0))e
TWk0l0+TMjk0l0=
P
j0 e
TMj0k0l0
:
In the M-step, we maximize lcn with IfXi = xj; Hi = (hk; hl)g replaced by !ijkl. The
maximization is carried out by the quasi-Newton algorithm. Starting with  = 0,
 = 0,  = 0 and k = log(ek=eK) (k = 1; : : : ; K   1), where the ek's are the MLEs
of the k's based on Gi (i = 1; : : : ; n), we iterate between the E-step and M-step until
the change in the observed-data log-likelihood is negligible.
We can estimate the limiting covariance matrix of b and bF by inverting the (observed-
data) information matrix for all the parameters including the jump sizes of bF . The
information matrix is obtained via the Louis (1982) formula. We can also estimate
the limiting covariance matrix of b by using the prole likelihood function pln() 
maxF logLn(; F ). Particularly, the (s; t)th element of the inverse covariance matrix ofb can be estimated by   2n npln(b+nes+net) pln(b+nes) pln(b+net)+pln(b)o,
where n is a constant of order n
 1=2, and es, and et are the sth and tth canonical vec-
tors. We calculate pln() via the EM algorithm by holding  constant in both the
E-step and M-step.
Theoretical Results
We impose the following conditions.
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CONDITION 2.1 If P;;(YjX; H) = Pe;e;e(YjX; H) for any H = (h; h) and H =
(h; hy), then  = e,  = e, and  = e.
CONDITION 2.2 If there exists a constant vector  such that Tr;; logP;;(YjX; H) =
0 for any H = (h; h) and H = (h; hy), then  = 0.
CONDITION 2.3 If there exists a function a(H) and a constant vector b such that
a(H) + bTD(X; H) = 0 with probability one, then a = 0 and b = 0.
REMARK 2.3 Condition 2.1 ensures that (;; ) are identiable from the geno-
type data while Condition 2.2 ensures nonsingularity of the information matrix. All
commonly used regression models, particularly generalized linear (mixed) models with
design vectors in the form of (2.1), satisfy these two conditions. Condition 2.3 pertains
to the identiability of . This condition holds under all common modes of inheritance
for the s;k;l provided that X is linearly independent given H.
LEMMA 2.1 If two sets of parameters (; F ) and (e; eF ) yield the same joint distribution
of the data, then  = e and F = eF .
Proof: Suppose that
X
H2S(G)
P;;(YjX; H)P;F (XjH)P(H) =
X
H2S(G)
Pe;e;e(YjX; H)Pe; eF (XjH)Pe(H):
Letting G = 2h or G = h+ hy and integrating over Y on both sides, we obtain
P;F (XjH)P(H) = Pe; eF (XjH)Pe(H):
Integrating over X on both sides then yields that P(H) = Pe(H): By Lemma 1 of Lin
and Zeng (2006),  = e. Thus, P;F (XjH) = Pe; eF (XjH). It follows from the denition
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of P;F (XjH) that
expf(   e)TD(X; H)gf(X)ef(X) =
R
x
expfTD(x; H)gdF (x)R
x
expfeTD(x; H)gd eF (x) :
By setting H = (h0; h
0
0), we obtain D(X; H) = 0, so the above equation reduces to
f(x) = ef(x) for any x. It then follows from Condition 2.3 that  = e. Therefore,
P;;(Y jX; H) = Pe;e;e(Y jX; H) for any H = (h; h) or H = (h; hy). By Condition 2.1,
 = e,  = e and  = e.
LEMMA 2.2 If there exist a vector   (T;;;T ;T )T and a function  (x) with
E[ (X)] = 0 such that T l(0; F0) + lF0(0; F0)[
R
 dF0] = 0; where l is the score
function for , and lF0 [
R
 dF0] is the score function for F along the submodel F0 +

R
 dF0 with scalar , then  = 0 and  = 0.
Proof: We wish to verify that if there exist a vector   (T;;;T ;T )T and a
function  (x) with E[ (X)] = 0 such that
T l(0; F0) + lF0(0; F0)[
Z
 dF0] = 0; (2:10)
where l is the score function for , and lF0 [
R
 dF0] is the score function for F along
the submodel F0+ 
R
 dF0 with scalar , then  = 0 and  = 0. To this end, we set
G = 2h or G = h+ hy. Then (2.10) becomes
T;;r;; logP0;0;0(YjX; H) + Tr logP0(H)
+TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+ (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0: (2:11)
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Taking the expectation with respect to P0;0;0(YjX; H) yields
Tr logP0(H) + TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+ (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0: (2:12)
Since D(x; H) = 0 for any x under H = (h0; h00), we have
Tr logP0(h0; h00) +  (X) 
Z
x
 (x)dF0(x) = 0:
This implies that  (x) is constant over x, so  = 0. Thus, (2.12) reduces to
Tr logP0(H) + TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0:
By Condition 2.3,  = 0. It then follows from Lemma 1 of Lin and Zeng (2006) that
 = 0. Hence, (2.11) reduces to 
T
;;r;; logP0;0;0(YjX; H) = 0: By Condition
2.2,  = 0,  = 0, and  = 0.
THEOREM 2.1 Under Conditions 2.1-2.3, jb   0j+ supx j bF (x)  F0(x)j ! 0 almost
surely. In addition, n1=2(b 0) converges in distribution to a zero-mean normal random
vector whose covariance matrix attains the semiparametric eciency bound.
Proof: We rst prove the consistency of b and bF . Because b is bounded and bF is a
distribution function, it follows from Helly's selection theorem that, for any subsequence
of b and bF , there exists a further subsequence, still denoted as b and bF , such thatb !  and bF ! F  in distribution. It suces to show  = 0 and F  = F0.
Since bF maximizes the likelihood function and its jump sizes are positive, there exists
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a Lagrange multiplier b such that
1bFfXkg  
nX
i=1
P
H2S(Gi) Pb;b;b(YijXi; H)Pb(H) expfb
TD(Xi;H)g expfbTD(Xk;H)g
[
R
x expfbTD(x;H)gd bF (x)]2P
H2S(Gi) Pb;b;b(YijXi; H)Pb(H) expfb
TD(Xi;H)gR
x expfbTD(x;H)gd bF (x)
  b = 0;
where bFfXkg is the jump size of bF at Xk. Due to the constraint thatPk bFfXkg = 1,
the above equation implies that b = 0. Dene eF as a distribution function with jumps
at the Xk's such that the jump size is proportional to
24 nX
i=1
P
H2S(Gi) P0;0;0(YijXi; H)P0(H)
expfT0 D(Xi;H)g expfT0 D(Xk;H)g
[
R
x expfT0 D(x;H)gdF0(x)]2
P0;0;0(YijXi; H)P0(H) expf
T
0 D(Xi;H)gR
x expfT0 D(x;H)gdF0(x)
35 1 :
By the Glivenko-Cantelli theorem, eF uniformly converges to F0. In addition, bF is
absolutely continuous with respect to eF , and d bF=d eF converges uniformly to some
positive function g. Finally, since n 1 logfLn(b; bF )=Ln(0; eF )g  0, we can take the
limit as n!1. Thus, the Kullback-Leibler information for (; F ) is non-positive, so
the density under (; F ) is the same as the true density. It then follows from Lemma
2.1 that  = 0 and F  = F0. This establishes the consistency of (b; bF ). The weak
convergence of bF to F0 can be strengthened to the uniform convergence since F0 is a
continuous distribution function.
To derive the asymptotic distribution, we consider the score equation along the
submodel (b + v; d bF + (   R  d bF )), where v is a vector with norm bounded by 1,
and  is any function with
R
 dF0 = 0 and with total variation bounded by 1. The
score equation takes the form
p
n 
1(v;  )
T(b   0) +pnZ 
2(v;  )d( bF   F0) = Gn lT v + lF [ ]	+ op(1);
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where Gn denotes the empirical measure, l is the score function for 0, lF is the score
operator for F0, (
1;
2) is a linear operator of the rst-order Fredholm-type which
maps (v;  ) to the same space as (v;  ), and op(1) means a random variable converging
in probability to zero uniformly in v and  . By some algebra, (
1;
2)[v;  ] = 0 implies
that the Fisher information along the submodel is zero, so v = 0 and  = 0 by Lemma
2.2. Thus, (
1;
2) is invertible. We then verify all the conditions in Theorem 3.3.1 of
van der Vaart and Wellner (1996). Hence,
p
n(b   0; bF   F0) weakly converges to a
mean-zero Gaussian process.
In light of the above derivation, the inuence function for b is a linear combination
of some lT v + lF [ ]. Thus, the inuence function lies on the tangent space spanned
by the score functions and thus must be the ecient inuence function. This means
that b is asymptotically ecient in that its limiting covariance matrix attains the
semiparametric eciency bound.
2.6.2 Case-Control Studies with Rare Disease
Numerical Algorithm
We adopt the notation of Section 2.6.1. The E-step of the EM algorithm is the
same as in Section 2.6.1. In the M-step, the objective function to be maximized is
eln(;; ) = X
i;j;k;l
!ijkl

Yi
TZjkl + TWkl + TMjkl   log
X
j0
e
TMj0kl

  n1 log
(X
j;k;l
e
TZjkl+TWkl e
TMjklP
j0 e
TMj0kl
)
  n0 log
X
k;l
e
TWkl

;
where !ijkl is dened in Section 2.6.1. We use the Louis formula to calculate the
observed-data information matrix, whose inverse is used to estimate the asymptotic
covariance matrix of the NPMLEs; the prole likelihood method can also be used to
50
estimate the covariance matrix of b.
Theoretical Results
We impose the following identiability condition.
CONDITION 2.4 If  + TZ(X; H) = e + eTZ(X; H) for any H = (h; h) and
H = (h; hy), then  = e and  = e.
LEMMA 2.3 If two sets of parameters (; F ) and (e; eF ) yield the same joint distribu-
tion, then  = e and F = eF .
Proof: Suppose that(P
H2S(G) expfTZ(X;H)gP;F (XjH)P(H)R
x
P
H expfTZ(x;H)gP;F (xjH)P(H)dx
)Y X
H2S(G)
P;F (XjH)P(H)
1 Y
=
(P
H2S(G) expfeTZ(X; H)gPe; eF (XjH)Pe(H)R
x
P
H expfeTZ(x; H)gPe; eF (xjH)Pe(H)dx
)Y X
H2S(G)
Pe; eF (XjH)Pe(H)
1 Y
:
(2:13)
Setting Y = 0 and G = 2h or G = h+ hy in (2.13), we obtain
P;F (XjH)P(H) = Pe; eF (XjH)Pe(H):
Integrating over X on both sides yields P(H) = Pe(H), so  = e. Thus, P;F (XjH) =
Pe; eF (XjH). By the arguments in the proof of Lemma 2.1, f = ef and  = e. Letting
Y = 1 and G = 2h or G = h + hy in (2.13), we see that expf(   e)TZ(X; H)g must
be a constant. It then follows from Condition 2.4 that  = e.
LEMMA 2.4 If there exist a vector   (T ;T ;T )T and functions  (x) with
E[ (X)] = 0 such that
T l(0; F0) + lF (0; F0)[
Z
 dF0] = 0;
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where l is the score function for , and lF [
R
 dF0] is the score function for F along
the submodel F0 + 
R
 dF0, then  = 0 and  = 0.
Proof: We wish to show that if there exist a vector   (T ;T ;T )T and functions
 (x) with E[ (X)] = 0 such that
T l(0; F0) + lF (0; F0)[
Z
 dF0] = 0; (2:14)
where l is the score function for , and lF [
R
 dF0] is the score function for F along
the submodel F0 + 
R
 dF0, then  = 0 and  = 0. To this end, we choose Y = 0
and G = 2h or G = h+ hy. Then (2.14) becomes
Tr logP0(H) + TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+ (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0: (2:15)
With H = (h0; h
0
0), (2.15) reduces to 
T
r logP0(h0; h00)+ (X) 
R
x
 (x)dF0(x) = 0:
This implies that  (x) is constant, so it must be zero. Thus, (2.15) reduces to
Tr logP0(H) + TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0:
By Condition 2.3,  = 0, so (2.15) further reduces to 
T
r logP0(H) = 0: By
Lemma 1 of Lin and Zeng (2006),  = 0. Setting Y = 1 and G = 2h or G = h + h
y,
we see that TZ(X; H) must be a constant. By Condition 2.4,  = 0.
We provide a mathematical denition of rare disease in Condition 2.5 and state the
asymptotic results in Theorem 2.2.
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CONDITION 2.5 Pr(Yi = 1jXi; Hi) = an expfT0Z(Xi; Hi)g=[1+an expfT0Z(Xi; Hi)g],
i = 1; : : : ; n, where an = o(n
 1=2).
THEOREM 2.2 Assume that Conditions 2.3-2.5 hold and n1=n! q 2 (0; 1). Then jb 
0j+supx j bF (x) F0(x)j ! 0 almost surely, and n1=2(b 0) converges in distribution to
a zero-mean normal random vector whose covariance matrix attains the semiparametric
eciency bound.
Proof: Let ePn be the probability measure generated by the likelihood function given
in (2.8) and let Pn0 be the true likelihood function. Since an = o(n
 1=2), we have
log ePn=Pn0 ! ePn or Pn0 1. By LeCam's lemma, ePn and Pn0 are equivalent. Thus, the
asymptotic properties under the true likelihood is equivalent to those under the the
approximate likelihood given in (2.8). In other words, we can assume that data are
generated from (2.8). Hence, the conclusion of the theorem follows from the arguments
in the proof of Theorem 2.1.
2.6.3 Case-Control Studies with Known Disease Rate
Numerical Algorithm
The E-step is similar to that of Section 2.6.1. In the M-step, we use the Lagrange
multiplier  for the constraint
X
j;k;l
P;(Y = 1jxj; hk; hl)exp(
TWkl + TMjkl)P
j0 exp(
TMj0kl)
= p1
X
k;l
exp(TWkl):
The objective function to be maximized in the M-step is
eln(;;; ; ) = X
i;j;k;l
!ijkl

logP;(Yijxj ; hk; hl) + TWkl + TMjkl   log
X
j0
e
TMj0kl

 
X
j;k;l
P;(Y = 1jxj; hk; hl)eTWkl+TMjkl=
X
j0
e
TMj0kl   p1
X
k;l
e
TWkl

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 n log
X
k;l
e
TWkl

:
We can treat  as a free parameter in eln(;;; ; ), so that the constraint is auto-
matically met by setting the derivative with respect to  to zero. The maximization
can be carried out by the quasi-Newton method. The variances and covariances can be
estimated by the inverse information matrix or by the prole-likelihood method.
Theoretical Results
LEMMA 2.5 If two sets of parameters (; F ) and (e; eF ) yield the same joint distribu-
tion, then  = e and F = eF .
Proof: Suppose that
X
H2S(G)
P;(Y jX; H)P;F (XjH)P(H) =
X
H2S(G)
Pe;e(Y jX;H)Pe; eF (XjH)Pe(H):
Letting G = 2h or G = h+ hy, we have
P;(Y jX; H)P;F (XjH)P(H) = Pe;e(Y jX;H)Pe; eF (XjH)Pe(H): (2:16)
Set Y = 0 or 1 in (2.16). The summation of the two resulting equations yields
P;F (XjH)P(H) = Pe; eF (XjH)Pe(H):
By the arguments in the proof of Lemma 2.3,  = e, f = ef , and  = e. Then (2.16)
reduces to exp

(  e)+(  e)TZ(X; H)	 = 1. By Condition 2.4,  = e and  = e.
LEMMA 2.6 If there exist a vector   (;T ;T ;T )T and a function  with
E[ (X)] = 0 such that
T l(0; F0) + lF (0; F0)[
Z
 dF0] = 0;
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where l is the score function for , and lF [
R
 dF0] is the score function for F along
the submodel F0 + 
R
 dF0 that satises the constraint Pr(Y = 1) = p1, then  = 0
and  = 0.
Proof: We wish to show that if there exist a vector   (;T ;T ;T )T and functions
 with E[ (X)] = 0 such that
T l(0; F0) + lF (0; F0)[
Z
 dF0] = 0; (2:17)
where l is the score function for , and lF [
R
 dF0] is the score function for F along
the submodel F0 + 
R
 dF0 that satises the constraint Pr(Y = 1) = p, then  = 0
and  = 0. With G = 2h or G = h+ hy, (2.17) becomes
(+
T
Z(X; H))

Y   expf0 + 
T
0Z(X; H)g
1 + expf0 + T0Z(X; H)g

+Tr logP0(H)+TD(X; H)
 
T

R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+ (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0:
The dierence of the two equations under Y = 1 and Y = 0 yields +
T
Z(X; H) = 0.
By Condition 2.4,  = 0 and  = 0. It then follows from the arguments in the proof
of Lemma 2.4 that  = 0,  = 0, and  = 0.
THEOREM 2.3 Under Conditions 2.3-2.4, the results of Theorem 2.2 hold.
Proof: First, we prove the consistency. Since b is bounded and bF is a distribution func-
tion, for any subsequence of (b; bF ), there exists a further subsequence, still denoted as
(b; bF ), such that b ! , and bF weakly converge to F . The consistency will hold if
we can show that  = 0 and F  = F0. We abbreviate (x;x0; (h; h0); (h0; h00)) and
P;(Y jx; H)P(H) as (x; H) and q(;;;x; H; Y ), respectively. After dierentiat-
ing the log-likelihood function with respect to the jump sizes of F , we see that there
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exist some Lagrange multipliers b1 and b2 such that, for k = 1; : : : ; n,
1bFfXkg  
nX
i=1
P
H2S(Gi) q(b; b; b;Xi; H; Yi)(Xi;H)(Xk; H)=fRx (x;H)d bF (x)g2P
H2S(Gi) q(b; b; b;Xi;H; Yi)(Xi;H)= Rx (x;H)d bF (x)
 b2X
H
"
q(b; b; b;Xk; H; 1)(Xk; H)R
x
(x; H)d bF (x)   (Xk; H)
R
x
q(b; b; b;x; H; 1)(x; H)d bF (x)
fR
x
(x; H)d bF (x))g2
#
 b1 = 0:
In addition, b1 and b2 satisfy the constraint equations
nX
k=1
bFfXkg = 1;
nX
k=1
X
H
q(b; b; b;Xk; H; 1) (Xk; H)R
x
(x; H)d bF (x) bFfXkg = p1:
It follows that b1 = 0. Thus,
(
nX
i=1
P
H2S(Gi) q(b; b; b;Xi;H; Yi)(Xi;H)(Xk;H)=fRx (x;H)d bF (x)g2P
H2S(Gi) q(b; b; b;Xi; H; Yi)(Xi;H)= Rx (x; H)d bF (x)
+b2X
H
"
q(b; b; b;Xk; H; 1)(Xk; H)R
x
(x; H)d bF (x)   (Xk; H)
R
x
q(b; b; b;x; H; 1)(x; H)d bF (x)
fR
x
(x; H)d bF (x))g2
#) 1
= 1;
and each denominator on the left-hand side should be positive. This equation for b2
has a unique solution satisfying the above constraints. In addition, we can show thatb2=n is bounded with probability one. Thus, we can choose a further subsequence such
that b2=n! 2.
We construct a discrete distribution function eF such that eF ! F0 uniformly. The
sequence can be constructed along the lines of Lin and Zeng (2006, xA.4.6). AlthougheF is a distribution function, it may not satisfy the constraint that
Z
x
X
H
P0;0(Y = 1jx; H)P(H)P0;F (xjH)f(x)dx = p1:
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Thus, we modify the jump size of eF at Xk as [ eFfXkg + =n]=(1 + ) for some con-
stant  such that  satises the above constraint. It can be shown that the solution
exists and  ! 0. The modied distribution function eF then satises all the con-
straints. By the Glivenko-Cantelli theorem, bF is absolutely continuous with respect
to eF , and d bF=d eF (x) ! q(x) uniformly in x for some positive function q(). Since
n 1 logfLn(b; bF )=Ln(0; eF )g  0, we take limits. We conclude that the Kullback-
Leibler information for (; F ) is non-positive. Hence, Lemma 2.5 entails that  = 0
and F  = F0.
We now derive the asymptotic distribution. We obtain score functions by dier-
entiating logLn(; F ) with respect to b along the direction v and with respect to bF
along submodels with tangent direction  satisfying all the constraints and with the
total variation bounded by 1. The linearization of the score functions around the true
parameter value, together with the Donsker theorem, yields
n1=2


1(v;  )
T(b   0) + Z 
2(v;  )d( bF   F0) = n 1=2 nX
i=1
 
vTl + lF [ ]

+ op(1);
where 
  (
1;
2) corresponds to the information operator and has the form of
the rst-order Fredholm type, and l and lF are the score operators for  and F ,
respectively. According to Lemma 2.6, 
 is invertible. Thus, the weak convergence
follows from Theorem 3.3.1 of van der Vaart and Wellner (1996). In addition, b is an
asymptotically linear estimator for 0 with the inuence function in the score space,
so it follows from Proposition 3.3.1 of Bickel et al. (1993) that the limiting covariance
matrix of n1=2(b   0) attains the semiparametric eciency bound.
2.6.4 Cohort Studies
Numerical Algorithm
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We present the EM algorithm for the proportional hazards model. Suppose that
there are L distinct failure times t1; : : : ; tL. Let ftlg denote the jump size of  at
tl, and dl the number of failures at tl. In the E-step, we evaluate the conditional
expectations
!ijkl EfI(Xi = xj; Hi = (hk; hl))
eYi;i;Xi; Gig
=
I(Xi = xj; (hk; hl) 2 S(Gi))Rijkl(;; )=
P
j0 exp(
TMj0kl)P
(hk0 ;hl0 )2S(Gi)Rijk0l0(;; )=
P
j0 exp(
TMj0k0l0)
;
where Rijkl(;; ) = exp(i
TZjkl + TWkl + TMjkl  eTZjkl
P
m:tmeYi ftmg). In
the M-step, we maximize
eln(;; ;) = X
i;j;k;l
!ijkli log feYig+ X
i;j;k;l
!ijkl

i
TZjkl + TWkl + TMjkl
  log
X
j0
exp(TMj0kl)

  eTZjkl
X
m:tmeYi
ftmg

  n log
nX
k;l
exp(TWkl)
o
:
The estimate for ftmg is given explicitly by dm
P
i:eYitmPj;k;l !ijkleTZjkl ; and the
estimate for  solves the equation
X
i;j;k;l
!ijkliZjkl  
LX
m=1
dm
P
i:eYitmPj;k;l !ijklZjkleTZjklP
i:eYitmPj;k;l !ijkleTZjkl = 0:
The remaining parameters can be estimated by maximizing
X
i;j;k;l
!ijkl

TWkl + TMjkl   log
X
j0
exp(TMj0kl)

  n log
nX
k;l
exp(TWkl)
o
:
We can estimate the asymptotic variances and covariances by the inverse information
matrix or the prole-likelihood method. For other transformation models, we may
use the Laplace transformation to convert the estimation problem into that of the
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proportional hazards model with a random eect; see Zeng and Lin (2007).
Theoretical Results
We impose the following conditions:
CONDITION 2.6 There exists a positive constant 0 such that Pr(C   jX; G) =
Pr(C =  jX; G)  0 almost surely, where  corresponds to the end of the study.
CONDITION 2.7 The true value 0(t) of (t) is a strictly increasing function in [0;  ]
and is continuously dierentiable. In addition, 0(0) = 0 and 
0
0(0) > 0.
LEMMA 2.7 If two sets of parameters (; F;) and (e; eF; e) yield the same joint
distribution, then  = e, F = eF and  = e.
Proof: Suppose that
X
H2S(G)

0(eY )eTZ(X;H)Q0((eY )eTZ(X;H)) expn Q((eY )eTZ(X;H))oP;F (XjH)P(H)
=
X
H2S(G)
e0(eY )eeTZ(X;H)Q0(e(eY )eeTZ(X;H)) expn Q(e(eY )eeTZ(X;H))oPe; eF (XjH)Pe(H):
We choose  = 1 and integrate eY from 0 to y on both sides to obtain the equation
X
H2S(G)

1  expf Q((y)eTZ(X;H))g

P;F (XjH)P(H)
=
X
H2S(G)

1  expf Q(e(y)eeTZ(X;H))gPe; eF (XjH)Pe(H): (2:18)
We obtain a second equation by setting  = 0 and eY = y. The summation of the two
equations yields
X
H2S(G)
P;F (XjH)P(H) =
X
H2S(G)
Pe; eF (XjH)Pe(H):
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By the arguments in the proof of Lemma 2.1,  = e, f = ef and  = e. By letting
G = 2h or G = h+ eh in (2.18), we have (y)eTZ(X;H) = e(y)eeTZ(X;H), which entails
 = e and  = e under Condition 2.4.
LEMMA 2.8 If there exist a vector   (T ;T ;T )T and functions  (x) and (t)
with E[ (X)] = E[(Y )] = 0 such that
T l(0; F0;0) + lF (0; F0;0)[
Z
 dF0] + l(0; F0;0)[
Z
 d0] = 0;
where l is the score function for , lF [
R
 dF0] is the score function for F along the
sub-model F0+
R
 dF0, and l[
R
 d0] is the score function for  along the sub-model
0 + 
R
 d0, then  = 0,  = 0 and  = 0.
Proof: We wish to show that if there exist a vector   (T ;T ;T )T and functions
 (x) and (t) with E[ (X)] = E[(Y )] = 0 such that
T l(0; F0;0) + lF (0; F0;0)[
Z
 dF0] + l(0; F0;0)[
Z
 d0] = 0; (2:19)
where l is the score function for , lF [
R
 dF0] is the score function for F along the
sub-model F0+
R
 dF0, and l[
R
 d0] is the score function for  along the sub-model
0 + 
R
 d0, then  = 0,  = 0 and  = 0. With  = 1, (2.19) becomes
X
H2S(G)
00(eY )eT0 ZQ0(0(eY )eT0 Z) expn Q(0(eY )eT0 Z)oP0(H) expfT0D(X; H)gf0(X)R
x
expfT0D(x; H)gdF0(x)

(
TZ +
h
Q00(0(eY )eT0 Z)   Q0(0(eY )eT0 Z)2i0(eY )eT0 ZTZ
Q0(0(eY )eT0 Z)
+(eY )+
h
Q00(0(eY )eT0 Z)   Q0(0(eY )eT0 Z)2i R eY0 (t)d0(t)eT0 Z
Q0(0(eY )eT0 Z) +Tr logP0(H)
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+TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+ (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
)
= 0: (2:20)
In the above equation, we integrate eY from 0 to  . We also let  = 0 and eY =  in
(2.19). The summation of these two equations with G = 2h or G = h+ hy yields
Tr logP0(H) + TD(X; H) 
T
R
x
expfT0D(x; H)gD(x; H)dF0(x)R
x
expfT0D(x; H)gdF0(x)
+  (X) 
R
x
expfT0D(x; H)g (x)dF0(x)R
x
expfT0D(x; H)gdF0(x)
= 0:
It follows from the arguments in the proof of Lemma 2.2 that  = 0,  = 0,
and  = 0. By letting G = 2h or G = h + hy and Y = 0 in (2.20), we obtain
TZ(X; H) + (0) = 0: It then follows from Condition 2.4 that  = 0 and (0) = 0.
Thus, (2.20) reduces to
(eY ) +
h
Q00(0(eY )eT0 Z)   Q0(0(eY )eT0 Z)2i R eY0 (t)d0(t)eT0 Z
Q0(0(eY )eT0 Z) = 0
for H = (h; h). Since Q is strictly increasing, we conclude that (y) = 0 for any y.
THEOREM 2.4 Under the conditions of Theorem 2.3 and Conditions 2.6-2.7, jb  
0j + supx j bF (x)   F0(x)j + supt2[0; ] jb(t)   0(t)j ! 0 almost surely. In addition,
n1=2(b 0; b 0) converges weakly to a zero-mean Gaussian process in Rdl1([0;  ]),
where d is the dimension of 0, and l
1([0;  ]) is the space of all bounded functions on
[0;  ] equipped with the supremum norm. Furthermore, the limiting covariance matrix
of b attains the semiparametric eciency bound.
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Proof: First, we show that b is uniformly bounded in [0;  ] as n ! 1. Note that b
maximizes eLn()  Ln(b;; bF )=Qni=1 bFfXig. Clearly,
eLn()  c0 nY
i=1
X
H2S(Gi)
n
0(eYi)eTZ(Xi;H)Q0  (eYi)eTZ(Xi;Hi)oi expn Q (eYi)eTZ(Xi;Hi)o
for some constant c0. According to the conditions of this theorem and Appendix B of
Zeng and Lin (2007), eLn()  c1Qni=1 h0(eYi)i(1 + (eYi)) (i+0)i for some positive
constants c1 and 0. By the partitioning arguments in the proof of Theorem 1 of Zeng
and Lin (2007), we can show that if b() is unbounded, then the dierence between
Ln(b; b; bF ) and Ln(0; e; bF ), where e is a step function converging to 0, diverges to
 1. Thus, b() must be bounded with probability one.
Using the above result and the arguments in the proof of Theorem 2.3, we choose a
uniformly convergent subsequence from any subsequence of (b; b; bF ). By the Glivenko-
Cantelli theorem and the property of the Kullback-Leibler information, the limit of
the convergent subsequence must be the true parameters (0;0; F0). The asymptotic
distribution of b; b and bF follows from the arguments used in the proof of Theorem
2.3.
2.6.5 More Numerical Results
We conducted simulation studies in the set-up of Chen et al. (2009). Specically, we
generated haplotypes under HWE from the distribution given in Table 1 of Chen et al.
(2009) and generated a binary environmental covariate X with Pr(X = 1) = 0:3,
1;3 = 0 or  :4 and 1;j = 0 (j 6= 3). Given H and X, the disease status was generated
from model (13) of Chen et al. (2009).
For each simulated data set, we calculated the proposed estimator of  allowing for
gene-environment dependence and the Lin-Zeng estimator assuming gene-environment
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independence, denoted as bdep and bind, respectively. Given these two estimators, we
constructed two empirical Bayes estimators using formula (7) of Chen et al. (2009).
Specically, the multivariate shrinkage estimator of  is
bEB1 = bdep +K(bind   bdep);
where K = V

V + (bind   bdep)(bind   bdep)T 1; and V is the estimated covariance
matrix of (bind  bdep); the component-wise shrinkage estimator of the jth component
of  is bEB2;j = bdep;j + kj(bind;j   bdep;j);
where bind;j and bdep;j are the jth components of bind and bdep, kj = vj=vj + (bind;j  bdep;j)2; and vj is the jth diagonal element of V.
Write  = (T;T)T, where  denotes all nuisance parameters (including nite-
dimensional nuisance parameters and jump sizes of nuisance functions). Also, let ind
and dep be the probability limits of bind and bdep. We note the following representations
bind   ind = Ip 0 I 1ind(ind) nX
i=1
Uind;i(

ind) + op(n
 1=2);
and bdep   dep = Ip 0 I 1dep(dep) nX
i=1
Udep;i(

dep) + op(n
 1=2);
where Uind;i() and Udep;i() are the ith subject's contributions to the score functions
of  under the Lin-Zeng and proposed methods, respectively, Iind() and Idep() are
the corresponding information matrices, Ip is the p  p identity matrix, and 0 is the
p  q zero matrix, with p and q being the dimensions of  and , respectively. Thus,
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we estimate the covariance matrices for bind and bdep as follows:
cvar(bind)  Ip 0 I 1ind(bind)n nX
i=1
Uind;i(bind)UTind;i(bind)oI 1ind(bind)Ip 0T ;
cvar(bdep)  Ip 0 I 1dep(bdep)n nX
i=1
Udep;i(bdep)UTdep;i(bdep)oI 1dep(bdep)Ip 0T ;
ccov(bind; bdep)  Ip 0 I 1ind(bind)n nX
i=1
Uind;i(bind)UTdep;i(bdep)oI 1dep(bdep)Ip 0T :
The simulation results for the dominant and recessive models are presented in Table
2.6, in the same format as Tables 2 and 3 of Chen et al. (2009). Our results for
the Lin-Zeng estimator (i.e., bind) are similar to those of Chen et al.'s (2009) model-
based estimator, especially under the recessive model. Under the dominant model,
the proposed estimator (i.e., bdep) tends to be more ecient than Chen et al. (2009)'s
model-free estimator, particularly in estimating gene-environment interactions. The
eciency gain is much more substantial under the recessive model, for both main eects
and interactions. Consequently, our empirical Bayes estimators are more ecient than
Chen et al.'s, especially under the recessive model.
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Table 2.6: Simulation results of the mean square error (bias of the parameter estimator)
for the empirical Bayes estimators under dominant and recessive models
n1 = n0 = 150 n1 = n0 = 300 n1 = n0 = 600
Dominant Model H H X H H X H H X
1;3 = 0 bdep .109(-.016) .292(.024) .054(-.008) .141(.003) .025(-.006) .069(-.007)bind .097(-.001) .203(-.002) .049(.004) .095(-.022) .023(.004) .047(-.031)bEB1 .106(-.018) .274(.024) .054(-.007) .137(.001) .025(-.005) .067(-.008)bEB2 .101(-.013) .234(.016) .052(-.003) .118(-.007) .024(-.002) .059(-.016)
1;3 =  :4 bdep .111(-.008) .310(.044) .051(-.005) .156(.005) .026(-.005) .074(-.013)bind .120(.133) .375(-.398) .062(.128) .275(-.416) .038(.122) .225(-.418)bEB1 .107(-.004) .293(.026) .051(-.001) .155(-.008) .026(-.002) .074(-.022)bEB2 .107(.028) .290(-.072) .051(.021) .163(-.079) .026(.012) .081(-.065)
Recessive Model
1;3 = 0 bdep .099(-.048) .261(-.049) .049(-.027) .127(-.031) .029(-.023) .073(-.023)bind .095(-.057) .197(-.043) .047(-.030) .092(-.034) .026(-.023) .052(-.031)bEB1 .097(-.050) .239(-.046) .049(-.028) .115(-.030) .028(-.023) .066(-.024)bEB2 .096(-.054) .225(-.047) .048(-.030) .108(-.031) .027(-.024) .062(-.026)
1;3 =  :4 bdep .087(-.050) .339(-.065) .044(-.026) .173(-.031) .026(-.022) .088(-.032)bind .095(.117) .778(-.720) .065(.147) .621(-.699) .047(.149) .536(-.678)bEB1 .087(-.039) .352(-.107) .044(-.020) .177(-.053) .026(-.018) .090(-.044)bEB2 .087(-.029) .370(-.170) .044(-.015) .185(-.080) .026(-.015) .094(-.069)
NOTE: bdep and bind pertain to the proposed estimator allowing for gene-environment
dependence and the Lin-Zeng estimator assuming gene-environment independence,
respectively. H and H X stand for main haplotype eect and
haplotype-environment interaction. Each entry is based on 1,000 replicates.
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Chapter 3
Analysis of Untyped SNPs:
Maximum Likelihood and
Imputation Methods
3.1 Introduction
This chapter provides comprehensive comparisons of (single) imputation and maximum
likelihood methods under cross-sectional and case-control designs. We expand the ap-
proach of Lin et al. (2008) to encompass both cross-sectional and case-control studies.
In addition, we develop a tagging-based imputation strategy. We establish the theoret-
ical properties of the proposed imputation method and conduct extensive simulation
studies to evaluate the performance of the imputation and maximum-likelihood meth-
ods in testing/estimating genetic eects and gene-environment interactions. We apply
the two methods to the GWAS data from the Wellcome Trust Case-Control Consortium
(WTCCC) (Burton et al., 2007).
3.2 Methods
3.2.1 Imputation
Suppose that we are interested in a particular untyped SNP, whose genotype is denoted
by Gu. Let Y denote the phenotype of interest, which can be quantitative or qualitative.
Also, let X denote a set of environmental factors. We characterize the eects of genetic
and environmental factors on the phenotype through the conditional density function
P;;(Y jGu;W), where W consists of X and the genotypes of typed SNPs, and , 
and  pertain to the intercept, regression parameters, and nuisance parameters (e.g.,
error variance), respectively. (If we are interested in the marginal eect of Gu, thenW
is an empty set.) We formulate P;;(Y jGu;W) through a generalized linear regression
model with linear predictor +TZ(Gu;W), where Z(Gu;W) is a vector-function of
Gu and W under a particular mode of inheritance. We assume the additive mode
of inheritance here, although all the formulas can be easily modied to accommodate
other modes of inheritance. For a quantitative trait, we specify the linear regression
model:
Y =  + TZ(Gu;W) + ;
where  is zero-mean normal with variance 2. For a binary trait, it is natural to use
the logistic regression model:
Pr(Y = 1jGu;W) = e
+TZ(Gu;W)
1 + e+
TZ(Gu;W) : (3:1)
We use the LD information from a reference panel to select a set of (M   1) typed
SNPs that provides the most accurate prediction of the untyped SNP, where M is a
small number, which is set to ve here. The accuracy of prediction is measured by
R2 of Stram (2004). The M -locus genotype G consists of Gu and Gt, where Gt is the
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genotype of the (M   1) typed SNPs. Suppose that the M SNPs have a total of K
haplotypes. For k = 1; : : : ; K, let hk denote the kth haplotype, and k denote the
frequency of hk. Assume that the HWE holds. For a reference panel of en trios, the
likelihood for  = (1; : : : ; K)
T is
LR() =
enY
j=1
X
(hk;hl;hk0 ;hl0 )Gj
klk0l0 ; (3:2)
where Gj = (GFj; GMj; GCj) is the genotype data for the jth trio with the M -locus
genotypes GFj, GMj and GCj for the father, mother and child, respectively, and
(hk; hl; hk0 ; hl0)  Gj means that (hk; hl) is compatible with GFj, (hk0 ; hl0) is compatible
with GMj, and (hk; hk0), (hk; hl0), (hl; hk0), or (hl; hl0) is compatible with GCj.
By maximizing LR() given in equation (3.2) via the EM algorithm, we obtain
the maximum-likelihood estimator e = (e1; : : : ; eK)T. Assuming that the haplotype
frequencies are the same between the study population and the external panel, we can
estimate the probability distribution of Gu from the observed values of Gt for each
study subject according to the formula
Pr(Gu = gj Gt; e) = P(hk;hl)(Gt;Gu=g) ekelP
g0=0;1;2
P
(hk;hl)(Gt;Gu=g0) ekel ; g = 0; 1; 2; (3:3)
where (hk; hl)  (Gt; Gu = g) means that (hk; hl) is compatible with (Gt; Gu = g).
We use this (estimated) probability distribution to impute the unknown value of Gu,
either as the expected count (i.e., dosage) or the most likely value of Gu. We replace
the unknown values of Gu by the imputed values for all study subjects to create a
\complete" data set, which is then analyzed by standard regression methods.
In the Appendix, we prove that the above imputation method yields a valid test
of the null hypothesis H0 : G = 0 under the linear predictor  + GuGu + 
T
WW,
where Gu and W pertain to the eects of Gu and W, respectively, provided that Gt
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is independent of Y conditional on W. This result holds for both cross-sectional and
case-control studies, even when the reference panel and the study sample are drawn from
dierent underlying populations. However, the estimator of Gu is generally biased with
underestimated variance when Gu 6= 0, and type I error may not be properly controlled
for other hypotheses.
3.2.2 Maximum Likelihood
Let H denote the diplotype associated with the M -locus genotype G. We write
H = (hk; hl) if the diplotype consists of haplotypes hk and hl. In the previous sub-
section, we formulate the eects of G and X through the conditional density function
P;;(Y jGu;W), where W consists of Gt and X. In this subsection, we represent
the same regression model in the form of P;;(Y jG(hk; hl);X), where G(hk; hl) de-
note the genotype G induced by the diplotype (hk; hl). We assume that H and X are
independent.
Let n denote the total number of study subjects. For i = 1; : : : ; n, let Yi, Gti and
Xi denote the values of Y , Gt and X on the ith subject. For a cross-sectional study,
the likelihood for  = (;T; T)T and  takes the form
LS(;) =
nY
i=1
X
(hk;hl)Gti
P;;
 
YijG(hk; hl);Xi

kl; (3:4)
where (hk; hl)  Gti means that the diplotype (hk; hl) is compatible with genotype Gti.
For case-control studies, we assume the logistic regression model given in (3.1) with
the linear predictor +TZ(G(hk; hl);X). Because the sampling is conditional on the
case-control status, the likelihood takes the retrospective form
Qn
i=1 P (Gti;XijYi). If
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there are no environmental factors and the disease is rare, then this likelihood becomes
LS(;) =
nY
i=1
P
(hk;hl)Gti e
Yi
TZ(G(hk;hl))klP
k;l e
Yi
TZ(G(hk;hl))kl
; (3:5)
where  = . In the presence of X, the retrospective likelihood involves the unknown
distribution of X, which is high-dimensional. We eliminate the distribution of X by the
prole-likelihood approach (Lin and Zeng, 2006) and replace (3.5) with the following
prole likelihood:
LS(;) =
nY
i=1
P
(hk;hl)Gti e
Yif+TZ(G(hk;hl);Xi)gklP
k;l;y e
yf+TZ(G(hk;hl);Xi)gkl
;
where  = (;T)T,  is an unknown constant, and the summation in the denominator
is taken over k; l = 1; : : : ; K and y = 0; 1.
The likelihood that combines the study data and the reference panel is LC(;) =
LS(;)LR(), where LR() is given in equation (3.2). We maximize this combined
likelihood via the Newton-Raphson algorithm. We set the initial value of  at e, the
maximizer of LR(). To improve numerical stabilities, we exclude the haplotypes whose
estimated frequencies are 0 or very close to 0, i.e., less than max(2=n; 0:001). The
maximum-likelihood estimator (MLE) of (;) is consistent, asymptotically normal
and asymptotically ecient.
Note that the likelihood for case-control studies was previously given in Lin et al.
(2008) and is reformulated in this section to conform with the notation for the impu-
tation method. The likelihood for cross-sectional studies is new.
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3.3 Simulation Studies
We carried out extensive simulation studies to evaluate the performance of the MLE
and imputation methods in realistic settings. We generated genotype data for various
sets of ve SNPs according to the LD patterns observed in the HapMap CEU sample.
For each SNP set, we chose one SNP to be untyped in the study data. For some SNP
sets, we picked more than one SNP to be untyped, one at a time, each representing
a dierent scenario. Table 3.1 lists the nine scenarios used in the simulation studies,
with R2 (Stram, 2004) ranging from .41 to .98.
We explored three types of association: (1) single-SNP eects, (2) gene-environment
interactions, (3) multi-SNP eects. For each type of model, we considered both cross-
sectional and case-control designs. Since the case-control design naturally requires a
binary trait, we focused on quantitative traits for cross-sectional studies. Thus, there
were six series of simulation studies. For each set-up, we simulated 10,000 data sets
with 2,000 study subjects and 60 trios. Under the case-control design, we set the
overall disease rate to be approximately 1% and selected an equal number of cases
and controls. We chose 60 trios for the reference panel so as to approximate the CEU
sample in the current version (i.e., phase 3) of the HapMap database, which consists
of 44 trios, 8 duos and 17 singletons. For each simulated data set, we applied the
MLE and imputation approaches. For the latter approach, we imputed the unknown
genotype by both the dosage and the most likely genotype, which are referred to as
the IMP-DOS and IMP-MLG methods, respectively. All the analysis was based on the
Wald statistic.
Our rst series of simulation studies was concerned with the (marginal) eect of an
untyped SNP on a quantitative trait in a cross-sectional study. We generated the trait
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value from the linear regression model
Y =  + Gu + ;
where  is standard normal and  = 0. Table 3.2 displays the results for various
values of . As expected, the MLE is virtually unbiased in all cases. IMP-DOS also
shows negligible bias, which is not surprising because conditional mean imputation is
known to yield consistent estimators of regression parameters under the linear model
(Little, 1992). The estimator of  produced by IMP-MLG is seriously biased towards
zero and the bias can be as much as 25% of the true parameter value. For non-zero ,
both IMP-DOS and IMP-MLG tend to underestimate the variances, so their condence
intervals have poor coverage probabilities. Under scenario S8, in which R2 = :98, the
coverage probability of the 99% condence interval of IMP-DOS is only 98% when
 = :9. IMP-MLG is much worse than IMP-DOS because it suers from both biased
estimation of parameter and underestimation of variance; see S1-S3. As predicted by
our theory, both IMP-DOS and IMP-MLG have appropriate type I error. In some cases
(i.e., S2, S3 and S5), IMP-DOS is slightly more powerful than MLE. This phenomenon
is attributed to the underestimation of variance by IMP-DOS. When R2 is large (e.g.,
S7-S9), all methods have the same power.
In our second series of studies, we simulated case-control data under the logistic
regression model
Pr(Y = 1jGu) = e
+Gu
1 + e+Gu
;
where  was set to  4:6 to yield disease rates of approximately 1%. The results are
summarized in Table 3.3. Unlike linear regression, IMP-DOS can produce substantial
bias under logistic regression; see S1{S3 and S5. MLE is now uniformly more powerful
than both IMP-DOS and IMP-MLG; this feature can be seen more clearly in Figure
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3.1. The power gain of MLE over imputation persists as R2 approaches 1 because MLE
exploits the HWE assumption whereas imputation does not. When R2 is low, the bias
of imputation (under non-linear models) also aects its power. Again, all three methods
have accurate control of type I error. As in cross-sectional studies, both IMP-DOS and
IMP-MLG tend to underestimate the variances (for non-zero ) and thus yield poor
condence interval coverage, especially when  is large and R2 is low.
Our third and fourth series of studies were focused on gene-environment interactions
under the cross-sectional and case-control designs, respectively. We generated data from
the same models as in the rst two series but with the linear predictors +1Gu+2X+
3GuX, where X is Bernoulli with Pr(X = 1) = 0:4. The results for cross-sectional
studies are displayed in Table 3.4. For detecting interactions, both IMP-DOS and IMP-
MLG produce condence intervals with poor coverage probabilities, especially when the
eects are large and the LD is low; see S1-S6. Both may lose control of type I error and
are substantially less powerful than MLE. The power gain of MLE is largely attributed
to its incorporation of gene-environment independence. The power dierence decreases
as R2 increases. In the extreme case of R2 = 1, the summation in (3.4) disappears
and MLE is equivalent to imputation. The results for case-control studies are shown in
Table 3.5. Both imputation methods yield biased estimates, poor condence interval
coverage and diminished power. The power dierence between MLE and imputation is
further illustrated in Figure 3.2. The power gain of MLE is again largely attributed to
its use of gene-environment independence. If we analyzed the imputed genotypes (either
the dosage or the most likely genotype) by the method of Chatterjee and Carroll (2005),
which also exploits gene-environment independence, then the power gain of MLE was
reduced considerably (results not shown).
Our last two series of studies dealt with multi-SNP eects. We set the untyped SNP
to be causal and included all ve SNPs in the joint analysis. For making inference on
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the eect of the untyped SNP, the performance of IMP-DOS and IMP-MLG is similar to
the rst two series of studies (results not shown). In particular, type I error is properly
controlled. This is not surprising because our theory indicates that imputation yields
a valid test of the untyped SNP even when there are environmental factors or typed
SNPs in the model. On the other hand, if the untyped SNP is associated with the trait,
the bias in the estimation of its eect can cause bias in estimating the null eects of
the typed SNPs. Indeed, both IMP-DOS and IMP-MLG can have inated type I error
in testing the eects of the typed SNPs and the ination of type I error becomes more
severe as the eect of the untyped SNP increases. Figure 3.3 and 3.4 display these
results for cross-sectional and case-control studies, respectively. As before, MLE has
accurate control of type I error.
3.4 WTCCC Data
We considered WTCCC data on type 1 diabetes (T1D). The database contains 1,963
subjects with T1D and 2,938 controls. For the typed SNPs, we applied the standard
Armitage trend test. For the untyped SNPs that are cataloged in the HapMap phase 3
database, we applied both MLE and IMP-DOS, with the phase 3 HapMap CEU sample
as the reference panel. For each untyped SNP, we rst identied the typed SNPs within
50 kb and then found a set of four that yields the largest R2. If there were fewer than
eight SNPs within 50 kb, we enlarged the window until a minimum of eight SNPs were
located. If there were more than twenty SNPs within 50 kb, we restricted our attention
to the closest twenty SNPs so as to reduce computation time.
As shown in Figure 3.5, MLE and IMP-DOS produce nearly identical quantile-
quantile (Q-Q) plots for the untyped SNPs, which are similar to that of the typed
SNPs. The deviations of the test statistics from the null distribution are minor except
in the extreme tails, which correspond to signicant associations. The over-dispersion
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parameter (i.e., the genomic control ) was estimated at approximately 1.05 for all three
plots. These results illustrate that, for single-SNP analysis, both MLE and imputation
have correct type I error.
Figure 3.6 displays the results of the association tests for both typed and untyped
SNPs on chromosomes 1, 6 and 12, which have the strongest evidence of association.
Both MLE and IMP-DOS were able to identify untyped SNPs that are more strongly
associated with the disease than typed SNPs, but MLE picked out those SNPs more
clearly. This is not surprising since MLE is expected to be more powerful than impu-
tation.
3.5 Discussion
We have presented two approaches to the analysis of untyped SNPs and investigated
their properties both theoretically and numerically. The maximum-likelihood approach
yields approximately unbiased parameter estimators, proper condence intervals and
accurate control of type I error. It tends to be more powerful than the imputation
approach, especially for case-control studies and in testing gene-environment interac-
tions. The maximum-likelihood method requires the study sample and reference panel
be generated from the same underlying population and may be numerically unstable
when the haplotype frequencies are low.
We have assumed gene-environment independence in the maximum likelihood ap-
proach. This assumption is satised in most applications and can substantially improve
the eciency of association analysis, especially in case-control studies (Chatterjee and
Carroll, 2005). It is possible to allow gene-environment dependence, but the analysis
will be more complicated and less ecient.
The imputation approach has some advantages over the maximum likelihood ap-
proach. Numerically, the former is more stable than the latter. For single-SNP tests,
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imputation has proper control of type I error even if the reference panel does not
match the study population. For testing other hypotheses, however, imputation may
have inated type I error. In general, imputation yields biased parameter estimators
and incorrect variance estimators. Because the bias can be upward and the variance
is underestimated, imputation can sometimes be more powerful than maximum like-
lihood. Thus, maximum likelihood and imputation are complementary to each other.
One possible strategy is to use imputation (with the dosage as the imputed value) in
the initial single-SNP tests and to use maximum likelihood for more complex analysis
once a region of disease association has been identied.
For cross-sectional studies, Xie and Stram (2005) showed that the score test based
on the dosage of the risk haplotype is asymptotically valid. We have shown that
imputation is asymptotically valid for single-SNP tests under both cross-sectional and
case-control designs whether the untyped SNP is imputed by the dosage or the most
likely genotype. Note that haplotype analysis does not involve external data whereas
analysis of untyped SNPs does.
Because it ignores the random variation of the reference panel, the imputation ap-
proach generally underestimates the variances of the parameter estimators. As the size
of the reference panel increases, the underestimation of variance becomes less severe
and thus condence intervals have better coverage probabilities. The size of the refer-
ence panel, however, has little inuence on the bias of imputation. On the other hand,
increasing the size of the reference panel reduces the variance of the MLE. Indeed, the
power of maximum likelihood improves at a faster rate than imputation as the reference
panel becomes larger, especially under the case-control design (results not shown).
Both MLE and imputation are computationally fast, and the relevant software is
available at our website. It took about 8 hours on a 64 bit, 30 GHz Intel Xeon machine
to perform the MLE analysis on chromosome 1 of the WTCCC GWAS data. Imputation
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was slightly faster. The computational savings of imputation will be more substantial if
there are multiple traits of interest because the untyped SNPs only need to be imputed
once.
For computational expediency, we used the signicance level of 0.01 in our simula-
tion studies. The relatively small number of replicates required for obtaining accurate
summary statistics at this signicance level allowed us to explore a very wide variety
of scenarios. It would be formidable to conduct extensive simulation studies at the
signicance level of 10 4 or lower, which would require at least 1 million replicates. We
repeated some of our simulation studies using the signicance level of 10 4, and the
basic conclusions regarding the relative merits of MLE and imputation remained the
same.
We have focused on tagging-based imputation. An alternative approach is to use
HMM (Browning and Browning, 2007; Marchini et al., 2007; Li et al., 2010). The latter
approach, which explores the LD information over a larger region and incorporates
population genetics knowledge, can yield more accurate prediction of untyped genotypes
in certain situations. We chose tagging over HMM in this chapter for several reasons:
(1) using the same amount of information to infer missing genotypes ensures that the
maximum-likelihood and imputation methods are compared on equal footing; (2) an
investigation by the imputation working group of GAIN (Manolio et al., 2007) revealed
that tagging is nearly as accurate as HMM (unpublished data); (3) tagging is much
simpler and faster than HMM and can handle much larger studies. We are currently
trying to incorporate HMM into the maximum likelihood framework. The conclusions of
this chapter regarding the relative merits of the maximum likelihood versus imputation
approaches are expected to hold when tagging is replaced by HMM.
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Table 3.1: Haplotype frequencies for the scenarios used in simulation studies
S1: R2 = :41, MAF=.39 S2: R2 = :59, MAF=.28 S3: R2 = :70, MAF=.15
Haplotype UTTTT Frequency TTTUT Frequency TTUTT Frequency
h1 00011 .0513 00100 .3171 00000 .0513
h2 00100 .0260 00101 .0988 00100 .1460
h3 01011 .0855 00111 .2027 01000 .6958
h4 01100 .3094 01001 .1518 10011 .1069
h5 01101 .1377 10100 .1059
h6 11011 .0085 10101 .0209
h7 11100 .1775 10111 .0793
h8 11101 .0247 11001 .0235
h9 11111 .1794
S4: R2 = :81, MAF=.33 S5: R2 = :84, MAF=.24 S6: R2 = :93, MAF=.15
Haplotype UTTTT Frequency TTUTT Frequency TTUTT Frequency
h1 00011 .2846 01101 .2852 00011 .0513
h2 00101 .0128 10100 .2510 00100 .0260
h3 00111 .0342 11000 .2393 01011 .0855
h4 10101 .2374 11100 .0321 01100 .3094
h5 10111 .1917 11101 .0963 01101 .1377
h6 11110 .2393 11110 .0961 11011 .0085
h7 11100 .1775
h8 11101 .0247
h9 11111 .1794
S7: R2 = :95, MAF=.09 S8: R2 = :98, MAF=.28 S9: R2 = :98, MAF=.29
Haplotype UTTTT Frequency TTUTT Frequency TTTTU Frequency
h1 00111 .3809 01000 .4231 01000 .4231
h2 01110 .2350 01010 .1154 01010 .1154
h3 01111 .2900 01011 .0043 01011 .0043
h4 11001 .0897 01111 .2821 01111 .2821
h5 11111 .0044 10010 .1751 10010 .1751
NOTE: \U" and \T" indicate the untyped and typed SNP positions, respectively. R2
is the squared correlation between the expected and true allele counts (Stram 2004).
MAF is the minor allele frequency of the untyped SNP.
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Table 3.2: Simulation results for studying the eect of an untyped SNP on a quantitative
trait under the cross-sectional design
MLE IMP-DOS IMP-MLG
 Bias SE SEE CP PW Bias SE SEE CP PW Bias SE SEE CP PW
S1 .0 .000 .051 .051 .989 .011 .000 .051 .051 .990 .010 .000 .041 .041 .989 .011
.1 .000 .051 .051 .990 .274 -.001 .051 .051 .990 .267 -.031 .041 .041 .965 .190
.2 .000 .052 .051 .990 .905 -.002 .051 .051 .990 .903 -.062 .042 .041 .857 .781
.6 .000 .053 .052 .990 1.00 -.007 .056 .053 .987 1.00 -.185 .047 .043 .063 1.00
.9 -.002 .054 .052 .988 1.00 -.010 .061 .056 .982 1.00 -.277 .053 .046 .001 1.00
S2 .0 .000 .046 .046 .991 .009 .000 .046 .046 .990 .010 .000 .036 .036 .991 .009
.1 .000 .046 .047 .991 .325 .000 .046 .046 .990 .336 -.026 .036 .036 .965 .309
.2 .000 .048 .048 .992 .960 .000 .048 .046 .988 .963 -.051 .038 .036 .843 .937
.6 .001 .057 .057 .988 1.00 -.001 .061 .047 .954 1.00 -.154 .048 .037 .151 1.00
.9 .000 .060 .060 .985 1.00 -.001 .077 .049 .903 1.00 -.231 .060 .038 .059 1.00
S3 .0 .000 .055 .054 .992 .008 .000 .055 .054 .991 .009 .000 .041 .041 .990 .010
.1 .000 .055 .055 .992 .217 .001 .055 .054 .989 .237 -.025 .041 .041 .977 .233
.2 .001 .057 .057 .991 .856 .001 .058 .054 .986 .871 -.050 .042 .041 .907 .863
.6 .001 .070 .070 .987 1.00 .004 .078 .055 .936 1.00 -.149 .046 .041 .172 1.00
.9 .000 .074 .073 .987 1.00 .006 .100 .056 .863 1.00 -.224 .051 .042 .033 1.00
S4 .0 .000 .037 .037 .989 .011 .000 .037 .037 .989 .011 .000 .035 .035 .989 .011
.1 .000 .037 .037 .989 .544 .000 .037 .037 .989 .544 -.007 .035 .035 .986 .540
.2 .000 .038 .037 .989 .998 -.001 .037 .037 .988 .998 -.013 .035 .035 .983 .997
.6 .000 .038 .038 .988 1.00 -.002 .039 .038 .986 1.00 -.039 .036 .036 .929 1.00
.9 .000 .039 .038 .989 1.00 -.003 .041 .038 .984 1.00 -.059 .036 .036 .829 1.00
S5 .0 .000 .041 .040 .991 .009 .000 .041 .040 .991 .009 .000 .036 .036 .991 .009
.1 .000 .041 .041 .991 .456 .000 .041 .040 .990 .463 -.012 .036 .036 .985 .463
.2 .001 .042 .042 .991 .991 .001 .042 .040 .988 .991 -.023 .036 .036 .971 .991
.6 .001 .048 .048 .988 1.00 .001 .050 .041 .966 1.00 -.071 .036 .036 .722 1.00
.9 .001 .052 .051 .987 1.00 .002 .060 .041 .929 1.00 -.106 .037 .036 .365 1.00
S6 .0 .000 .050 .050 .990 .010 .000 .050 .050 .990 .010 .000 .048 .047 .990 .010
.1 .000 .050 .050 .990 .286 .000 .050 .050 .990 .284 -.008 .048 .047 .988 .266
.2 .000 .050 .050 .990 .919 -.001 .050 .050 .990 .918 -.015 .048 .047 .985 .904
.6 .000 .050 .050 .990 1.00 -.003 .050 .050 .990 1.00 -.046 .048 .048 .943 1.00
.9 .000 .050 .049 .989 1.00 -.004 .051 .051 .991 1.00 -.069 .049 .049 .876 1.00
S7 .0 .000 .056 .056 .990 .010 .000 .056 .056 .990 .010 .000 .055 .055 .990 .010
.1 .000 .056 .056 .990 .215 .000 .056 .056 .990 .214 .000 .055 .055 .990 .215
.2 .000 .056 .056 .990 .844 .000 .056 .056 .990 .844 -.001 .055 .055 .990 .845
.6 .000 .056 .056 .990 1.00 .000 .056 .056 .990 1.00 -.003 .055 .055 .990 1.00
.9 .000 .056 .056 .990 1.00 .000 .056 .056 .990 1.00 -.004 .056 .056 .990 1.00
S8 .0 .000 .036 .036 .990 .010 .000 .036 .036 .990 .010 .000 .035 .035 .990 .010
.1 .000 .036 .036 .990 .590 .000 .036 .036 .990 .590 -.002 .035 .035 .991 .590
.2 .000 .036 .036 .991 .999 .000 .036 .036 .990 .999 -.003 .035 .035 .991 .999
.6 .000 .037 .037 .990 1.00 .000 .037 .036 .987 1.00 -.009 .035 .035 .988 1.00
.9 .000 .038 .038 .989 1.00 .000 .038 .036 .982 1.00 -.014 .035 .035 .984 1.00
S9 .0 .000 .036 .035 .990 .010 .000 .036 .035 .990 .010 .000 .035 .035 .990 .010
.1 .000 .036 .035 .990 .599 .000 .036 .035 .990 .599 -.001 .035 .035 .990 .598
.2 .000 .036 .035 .990 .999 .000 .036 .035 .990 .999 -.001 .035 .035 .990 .999
.6 .000 .036 .035 .990 1.00 .000 .036 .035 .990 1.00 -.004 .035 .035 .991 1.00
.9 -.001 .036 .035 .990 1.00 -.001 .036 .035 .989 1.00 -.005 .035 .035 .990 1.00
NOTE: S1-S9 denote the nine scenarios listed in Table 3.1. Bias and SE are the bias
and standard error of the parameter estimator. SEE is the mean of the standard error
estimator. CP is the coverage probability of the 99% condence interval. PW is the
type I error/power for testing zero parameter value at the .01 nominal signicance
level. Each entry is based on 10,000 replicates.
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Table 3.3: Simulation results for studying the eect of an untyped SNP on the risk of
disease under the case-control design
MLE IMP-DOS IMP-MLG
 Bias SE SEE CP PW Bias SE SEE CP PW Bias SE SEE CP PW
S1 .0 .001 .100 .099 .989 .011 .001 .101 .101 .990 .010 .001 .082 .082 .990 .010
.3 .000 .103 .101 .990 .651 -.010 .101 .100 .989 .633 -.093 .082 .081 .922 .483
.6 .000 .108 .106 .989 .999 -.031 .102 .099 .984 .999 -.190 .082 .081 .580 .993
.9 -.008 .115 .113 .986 1.00 -.070 .104 .100 .961 1.00 -.297 .083 .082 .156 1.00
S2 .0 -.002 .091 .090 .991 .009 -.001 .093 .092 .989 .011 -.001 .073 .072 .988 .012
.3 .000 .085 .084 .989 .844 .012 .094 .091 .987 .805 -.067 .075 .072 .934 .753
.6 -.002 .084 .082 .990 1.00 .046 .103 .092 .971 1.00 -.117 .083 .073 .757 1.00
.9 -.009 .084 .083 .989 1.00 .093 .115 .094 .919 1.00 -.157 .097 .075 .566 1.00
S3 .0 -.002 .106 .106 .992 .008 -.001 .109 .108 .989 .011 .000 .082 .082 .989 .011
.3 -.001 .099 .098 .991 .693 .012 .110 .105 .987 .651 -.067 .081 .079 .953 .641
.6 .000 .096 .096 .990 1.00 .047 .120 .103 .969 1.00 -.116 .082 .078 .841 1.00
.9 -.003 .096 .097 .989 1.00 .096 .136 .103 .915 1.00 -.153 .087 .078 .682 1.00
S4 .0 .000 .073 .073 .990 .010 .000 .075 .074 .989 .011 .000 .071 .070 .989 .011
.3 .001 .075 .074 .990 .929 .002 .078 .077 .990 .913 -.016 .074 .073 .986 .909
.6 .000 .077 .077 .989 1.00 .007 .082 .081 .990 1.00 -.028 .077 .077 .984 1.00
.9 -.006 .082 .081 .990 1.00 .011 .088 .087 .989 1.00 -.039 .083 .082 .979 1.00
S5 .0 .000 .079 .079 .989 .011 .000 .082 .081 .989 .011 .000 .072 .071 .989 .011
.3 .001 .086 .087 .990 .837 -.005 .085 .084 .988 .830 -.040 .074 .074 .977 .830
.6 .002 .103 .102 .989 1.00 -.023 .093 .088 .980 1.00 -.092 .078 .077 .912 1.00
.9 .009 .130 .127 .988 1.00 -.051 .102 .093 .961 1.00 -.154 .082 .081 .744 1.00
S6 .0 .000 .096 .097 .991 .009 .000 .100 .100 .991 .009 .000 .095 .095 .991 .009
.3 .001 .102 .103 .990 .634 .000 .105 .106 .989 .603 -.022 .100 .101 .989 .578
.6 -.002 .112 .112 .989 .999 -.007 .114 .114 .990 .997 -.049 .108 .108 .981 .996
.9 -.004 .122 .121 .989 1.00 -.014 .125 .123 .987 1.00 -.077 .118 .117 .964 1.00
S7 .0 .000 .109 .108 .991 .009 .000 .112 .111 .992 .008 .000 .112 .111 .992 .008
.3 -.001 .103 .102 .989 .632 -.001 .106 .106 .991 .601 -.002 .106 .105 .991 .599
.6 .000 .097 .098 .990 1.00 .001 .102 .102 .990 1.00 -.002 .101 .101 .990 1.00
.9 -.003 .096 .095 .989 1.00 -.001 .101 .100 .989 1.00 -.005 .100 .099 .989 1.00
S8 .0 .000 .070 .069 .989 .011 .000 .072 .071 .989 .011 .000 .071 .070 .989 .011
.3 .000 .066 .067 .990 .972 .002 .069 .070 .990 .962 -.003 .068 .069 .989 .962
.6 -.001 .066 .066 .990 1.00 .004 .071 .070 .990 1.00 -.006 .069 .069 .989 1.00
.9 -.006 .066 .066 .990 1.00 .005 .072 .071 .990 1.00 -.008 .070 .070 .991 1.00
S9 .0 .000 .069 .069 .988 .012 .000 .071 .071 .989 .011 .000 .071 .070 .989 .011
.3 .000 .067 .067 .992 .971 .000 .069 .069 .991 .960 -.001 .069 .069 .991 .960
.6 -.002 .066 .066 .991 1.00 -.001 .069 .069 .992 1.00 -.004 .069 .069 .992 1.00
.9 -.007 .067 .066 .989 1.00 -.002 .072 .071 .989 1.00 -.007 .071 .070 .988 1.00
NOTE: See the Note to Table 3.2.
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Table 3.4: Simulation results for studying gene-environment interactions under the
cross-sectional design with a quantitative trait
MLE IMP-DOS IMP-MLG
1 3 Bias SE SEE CP PW Bias SE SEE CP PW Bias SE SEE CP PW
S1 .5 .0 .000 .097 .096 .990 .010 -.002 .107 .107 .991 .009 -.001 .087 .087 .990 .010
.5 .2 .000 .095 .094 .990 .328 -.004 .108 .109 .991 .210 -.063 .088 .089 .970 .150
.5 .3 .000 .094 .093 .990 .740 -.005 .108 .111 .992 .531 -.094 .089 .090 .943 .385
.5 .9 .000 .092 .091 .990 1.00 -.012 .115 .121 .993 1.00 -.279 .098 .100 .409 1.00
1.2 .0 .000 .085 .084 .991 .009 -.002 .116 .123 .994 .006 -.001 .099 .102 .992 .008
S2 .5 .0 -.001 .092 .092 .991 .009 -.002 .097 .096 .990 .010 -.001 .076 .075 .991 .009
.5 .2 -.001 .092 .091 .990 .352 -.002 .098 .097 .989 .303 -.053 .077 .076 .964 .273
.5 .3 -.001 .092 .091 .990 .763 -.002 .100 .098 .989 .682 -.078 .078 .076 .926 .633
.5 .9 -.001 .091 .090 .991 1.00 -.003 .118 .103 .977 1.00 -.232 .092 .081 .377 1.00
1.2 .0 .000 .087 .087 .989 .011 -.002 .107 .105 .989 .011 -.001 .083 .083 .992 .009
S3 .5 .0 .000 .110 .110 .991 .009 .000 .113 .112 .989 .011 .000 .085 .084 .989 .011
.5 .2 .001 .110 .110 .990 .224 .001 .115 .112 .987 .223 -.050 .086 .085 .974 .218
.5 .3 .000 .111 .111 .989 .560 .002 .118 .113 .986 .541 -.075 .087 .085 .951 .533
.5 .9 .000 .110 .111 .991 1.00 .006 .144 .116 .964 1.00 -.224 .094 .087 .487 1.00
1.2 .0 .000 .108 .108 .990 .010 -.001 .124 .116 .984 .017 .000 .093 .088 .984 .016
S4 .5 .0 -.001 .077 .076 .988 .012 -.001 .077 .077 .990 .010 -.001 .073 .072 .989 .011
.5 .2 -.001 .077 .076 .988 .516 -.002 .077 .077 .990 .496 -.014 .073 .073 .988 .488
.5 .3 -.001 .077 .076 .988 .913 -.002 .078 .077 .991 .901 -.021 .073 .073 .987 .895
.5 .9 -.001 .076 .075 .988 1.00 -.004 .079 .080 .990 1.00 -.060 .074 .076 .966 1.00
1.2 .0 -.001 .076 .075 .988 .012 -.001 .080 .080 .990 .010 -.001 .076 .076 .990 .010
S5 .5 .0 -.001 .084 .083 .990 .011 -.001 .084 .083 .989 .011 -.001 .074 .073 .989 .011
.5 .2 -.001 .084 .083 .989 .432 -.001 .085 .083 .988 .432 -.025 .075 .073 .985 .432
.5 .3 -.001 .085 .084 .989 .842 -.001 .086 .084 .988 .840 -.036 .075 .074 .978 .840
.5 .9 -.001 .085 .084 .989 1.00 .000 .097 .085 .978 1.00 -.108 .077 .075 .872 1.00
1.2 .0 -.001 .084 .083 .988 .012 -.001 .089 .086 .987 .013 -.001 .078 .076 .987 .013
S6 .5 .0 -.001 .102 .101 .989 .011 .000 .102 .102 .990 .010 -.001 .097 .098 .990 .010
.5 .2 -.001 .102 .101 .989 .277 -.001 .102 .103 .990 .261 -.016 .098 .098 .990 .245
.5 .3 -.001 .101 .101 .989 .649 -.002 .102 .103 .990 .621 -.024 .098 .098 .989 .591
.5 .9 -.001 .101 .100 .989 1.00 -.005 .103 .105 .991 1.00 -.070 .099 .100 .973 1.00
1.2 .0 -.001 .099 .099 .989 .011 .000 .103 .105 .991 .009 -.001 .100 .101 .991 .009
S7 .5 .0 -.002 .114 .114 .991 .009 -.002 .114 .114 .991 .009 -.002 .114 .113 .991 .009
.5 .2 -.002 .114 .114 .991 .202 -.002 .114 .114 .991 .202 -.003 .114 .113 .991 .201
.5 .3 -.002 .114 .114 .990 .515 -.002 .114 .114 .991 .512 -.004 .114 .113 .991 .512
.5 .9 -.004 .114 .114 .990 1.00 -.003 .114 .114 .991 1.00 -.007 .114 .114 .991 1.00
1.2 .0 -.002 .114 .114 .990 .010 -.002 .115 .114 .991 .009 -.002 .114 .114 .991 .009
S8 .5 .0 .001 .073 .073 .989 .011 .001 .074 .073 .989 .011 .001 .072 .072 .989 .011
.5 .2 .001 .074 .073 .989 .572 .001 .074 .073 .989 .572 -.002 .072 .072 .989 .572
.5 .3 .001 .074 .073 .989 .939 .001 .074 .073 .990 .939 -.004 .072 .072 .989 .939
.5 .9 -.001 .074 .073 .989 1.00 .001 .075 .073 .989 1.00 -.013 .073 .072 .987 1.00
1.2 .0 .001 .074 .073 .990 .011 .001 .074 .073 .989 .011 .001 .073 .072 .989 .011
S9 .5 .0 .001 .073 .072 .990 .010 .001 .073 .072 .990 .010 .001 .073 .072 .990 .010
.5 .2 .001 .073 .072 .990 .579 .001 .073 .072 .990 .577 .000 .073 .072 .990 .577
.5 .3 .000 .073 .072 .990 .943 .001 .073 .072 .990 .942 -.001 .073 .072 .990 .943
.5 .9 -.001 .073 .072 .990 1.00 .000 .073 .073 .990 1.00 -.005 .073 .072 .989 1.00
1.2 .0 .001 .073 .072 .990 .010 .001 .073 .073 .990 .011 .001 .073 .072 .990 .010
NOTE: 2 = :2. See the Note to Table 3.2.
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Table 3.5: Simulation results for studying gene-environment interactions under the
case-control design
MLE IMP-DOS IMP-MLG
3 Bias SE SEE CP PW Bias SE SEE CP PW Bias SE SEE CP PW
S1 .0 .000 .151 .149 .990 .010 -.002 .210 .209 .990 .010 -.002 .169 .169 .991 .009
.5 -.008 .165 .163 .988 .679 -.021 .218 .216 .988 .359 -.157 .175 .175 .952 .270
.9 -.025 .188 .187 .987 .985 -.065 .233 .231 .985 .859 -.295 .187 .187 .840 .751
S2 .0 .000 .136 .135 .992 .008 -.001 .189 .189 .991 .009 -.001 .148 .147 .991 .009
.5 -.006 .140 .139 .991 .863 .032 .198 .194 .989 .565 -.103 .157 .152 .965 .521
.9 -.023 .153 .153 .989 1.00 .098 .216 .204 .978 .990 -.153 .174 .160 .927 .980
S3 .0 .002 .162 .160 .992 .008 .001 .226 .223 .991 .009 .000 .170 .168 .990 .010
.5 -.002 .160 .158 .990 .756 .034 .232 .223 .987 .424 -.100 .171 .168 .973 .421
.9 -.016 .167 .166 .987 1.00 .099 .247 .227 .977 .968 -.152 .177 .171 .948 .967
S4 .0 -.002 .110 .109 .988 .012 -.002 .154 .153 .990 .010 -.002 .145 .144 .990 .010
.5 -.011 .130 .129 .989 .882 .004 .169 .169 .990 .660 -.026 .160 .159 .989 .657
.9 -.036 .157 .158 .990 .996 .007 .193 .194 .990 .977 -.044 .182 .183 .989 .977
S5 .0 -.001 .118 .118 .992 .008 .001 .166 .166 .991 .009 .001 .146 .146 .991 .009
.5 -.011 .150 .150 .991 .756 -.014 .187 .185 .989 .521 -.072 .163 .163 .982 .521
.9 -.031 .200 .199 .991 .963 -.056 .221 .216 .987 .904 -.157 .191 .190 .965 .904
S6 .0 -.003 .146 .146 .990 .010 -.003 .205 .206 .992 .008 -.003 .196 .195 .993 .007
.5 -.017 .186 .185 .991 .521 -.005 .238 .235 .990 .329 -.041 .226 .223 .988 .307
.9 -.049 .243 .241 .993 .806 -.023 .282 .280 .991 .701 -.087 .268 .266 .989 .682
S7 .0 .003 .165 .163 .991 .009 .000 .230 .230 .990 .010 .000 .229 .229 .990 .010
.5 -.004 .157 .156 .991 .735 -.001 .227 .226 .988 .356 -.003 .226 .225 .989 .354
.9 -.015 .157 .156 .990 1.00 .000 .225 .226 .992 .926 -.004 .224 .225 .991 .926
S8 .0 .001 .104 .104 .991 .009 .000 .146 .146 .991 .009 .000 .144 .144 .991 .009
.5 -.007 .107 .107 .990 .985 .005 .149 .149 .991 .792 -.003 .147 .147 .991 .792
.9 -.025 .116 .116 .986 1.00 .008 .159 .157 .989 .999 -.006 .156 .155 .989 .999
S9 .0 .001 .104 .103 .991 .009 .000 .146 .145 .990 .010 .000 .145 .145 .990 .010
.5 -.007 .108 .107 .989 .983 .002 .148 .149 .989 .792 -.001 .147 .148 .990 .792
.9 -.026 .117 .116 .986 1.00 .000 .158 .157 .991 .999 -.006 .157 .156 .990 .999
NOTE: 1 = :0, 2 = :1. See the Note to Table 3.2.
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Figure 3.1: Power of testing the eect of an untyped SNP at the 1% nominal signicance
level under the case-control design. The solid, dashed and dotted curves pertain to
MLE, IMP-DOS and IMP-MLG, respectively.
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Figure 3.2: Power of testing gene-environment interactions at the 1% nominal signi-
cance level under the case-control design. The solid, dashed and dotted curves pertain
to MLE, IMP-DOS and IMP-MLG, respectively.
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Figure 3.3: Type I error for testing the null eect of a typed SNP on a quantitative trait
at the 1% nominal signicance level in the joint analysis involving a causal, untyped
SNP under the cross-sectional design. The solid, dashed and dotted curves pertain to
MLE, IMP-DOS and IMP-MLG, respectively.
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Figure 3.4: Type I error for testing the null eect of a typed SNP at the 1% nominal
signicance level in the joint analysis involving a causal, untyped SNP under the case-
control design. The solid, dashed and dotted curves pertain to MLE, IMP-DOS and
IMP-MLG, respectively.
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Figure 3.5: Q-Q plots for the single-SNP analysis of the T1D data from the WTCCC
study: (a) Armitage trend test for typed SNPs, (b) MLE for untyped SNPs, and (c)
IMP-DOS for untyped SNPs. Chi-squared statistics exceeding 30 are truncated. The
black curve in (a) pertains to 392,746 typed SNPs that pass the standard project lters,
have minor allele frequencies (MAF) > 1% and missing data rates < 1%, and have good
cluster plots. The black curves in (b) and (c) pertain to 819,727 untyped SNPs that
are cataloged in Phase 3 of HapMap with MAF > 1%. The Q-Q plots which exclude
all SNPs located in the regions of association listed in Table 3 of the WTCCC (Burton
et al., 2007) paper are superimposed in grey. The grey curves show that departures in
the extreme tails of the distributions of test statistics are due to regions with strong
signals for association.
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Figure 3.6: Results of single-SNP association tests for the WTCCC study of T1D. The
log10 p-values for typed SNPs and untyped SNPs are shown in blue circles and red
dots, respectively. The three rows correspond to chromosomes 1, 6 and 12, which have
the strongest evidence of association. The left column corresponds to the trend test
for the typed SNPs and the MLE method for the untyped SNPs. The right column
corresponds to the trend test for the typed SNPs and the IMP-DOS method for the
untyped SNPs. All typed SNPs pass the standard project lters, have MAF > 1% and
missing data rate < 1%, and have good cluster plots. All untyped SNPs have MAF
> 1% in HapMap.
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3.6 Appendix
We are interested in the eect of the untyped SNP genotype Gu on the phenotype Y
adjusted for the eects of covariates W (if there are any). The covariates, which are
required to be fully observed, may include environmental factors and typed SNPs and
are allowed to be correlated with the untyped SNP. The linear predictor is assumed to
take the form of +GuGu+
T
WW, where Gu and W represent the regression eects
of Gu and W, respectively. Write  = (Gu ;
T
W)
T. We are particularly interested in
testing the null hypothesis H0 : Gu = 0.
Let n denote the total number of study subjects. For i = 1; : : : ; n, let Yi, Gui
and Wi denote the values of Y , Gu and W on the ith subject. We replace Gui bybGui, where bGui is the imputed value of Gui based on equation (3.3), and then apply
standard likelihood methods to the imputed data set (Yi; bGui;Wi) (i = 1; : : : ; n). The
validity of such analysis does not follow from standard likelihood theory because the n
imputed values f bGuig (i = 1; : : : ; n) are correlated due to the presence of the estimatore in them.
We rst consider cross-sectional studies. The \likelihood" for  = (;T; T)T
based on the imputed data set takes the form L() =
Qn
i=1 P;;(Yij bGui;Wi). Denote
the resulting estimator by b. As mentioned above, standard likelihood theory is not
applicable to b because the n terms in L() are not independent.
Under H0 : Gu = 0, Y is related to W only and is independent of Gu given W.
Assume that Gt is independent of Y given W. (This assumption holds if Gt is inde-
pendent of Y or is part of W.) Then bGu, which is a function of Gt and e, is also
independent of Y givenW, regardless of the value of e. In other words, the regression
eects of bGu and W on Y are the same as those of Gu and W under H0. Denote the
reference panel by R. Conditional on R, the imputed values are uncorrelated, so that,
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under H0, the random vector I
1=2(b)(b   ) converges to a multivariate normal distri-
bution with mean zero and identity covariance matrix, where I() =  @2 logL()=@2.
Because the limiting distribution does not depend on R, the convergence also holds
unconditionally. Thus, standard likelihood methods can be used to test H0 (even if the
study sample and reference panel are drawn from dierent populations).
The above result hinges critically on the null hypothesis H0 : Gu = 0 under the
linear predictor + GuGu + 
T
WW, which ensures that
b converges to the true value
of  conditional on R. If Gu 6= 0, then the asymptotic distribution of b conditional
on R depends on R, so that the inverse information matrix I 1(b), which ignores the
variability in the reference panel, will underestimate the true variation of b. Thus, the
condence intervals for Gu will not have proper coverage probabilities unless Gu = 0.
It should also be pointed out that the validity of association testing is not guaranteed
if the linear predictor does not take the form of  + GuGu + 
T
WW.
We now consider the analysis of case-control data under the logistic regression model
Pr(Y = 1jGu;W) = e
+GuGu+
T
WW
1 + e+GuGu+
T
WW
:
Write  = (; Gu ;
T
W)
T. If Gu were observed on all study subjects, then the maximum
likelihood estimator of  (based on the prospective likelihood) would converge to 
and its covariance matrix would be consistently estimated by the inverse information
matrix, where  is the same as  except that  is replaced by a dierent constant
(Prentice and Pyke, 1979). Let b be the maximizer of the (prospective) likelihood
based on the imputed data:
L() =
nY
i=1
eYi(+Gu
bGui+TWWi)
1 + e+Gu bGui+TWWi :
It then follows from the above arguments for cross-sectional studies that, under H0 :
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Gu = 0, the random vector I
1=2(b)(b   ) converges to a multivariate normal distri-
bution with mean zero and identity covariance matrix, where I() =  @2 logL()=@2.
Thus, the association testing is valid. Again, the variance is underestimated by the
inverse information matrix if Gu 6= 0, and the association testing may not be valid for
other types of hypotheses.
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Chapter 4
A Likelihood-Based Framework for
Association Analysis of
Allele-Specic Copy Numbers
4.1 Introduction
In this chapter, we propose a framework for the integrated analysis of CNVs and SNPs
in association studies, including analysis of total copy numbers as a special case. We
allow for dierential errors. We focus on case-control studies, although our methods
can easily be modied for quantitative trait association analysis. We unify the ASCN
calling and association analysis into a single step, so that the ASCN calling is informed
by the phenotype and the association analysis fully accounts for the uncertainty in
the calling. We formulate the eects of CNVs and SNPs on the phenotype through
exible regression models, which can accommodate various genetic mechanisms and
gene-environment interactions. We construct appropriate likelihoods, which may in-
volve high-dimensional parameters. We establish the consistency, asymptotic normal-
ity, and asymptotic eciency of the maximum likelihood estimators by appealing to
modern asymptotic techniques. We develop ecient and reliable numerical algorithms.
We conduct extensive simulation studies to assess the performance of the proposed
methods and compare them with existing approaches. We illustrate our methods with
a GWAS data of schizophrenia (Shi et al., 2009).
4.2 Methods
4.2.1 Notation and Model Assumptions
Suppose that the SNP has two alleles, A and B. Denote the total copy number and the
B allele copy number by K and L, respectively, where 0  L  K  S, and S is the
maximum copy number we will consider. Let Y be the phenotype of interest and X
be a set of environmental factors. For case-control studies, the conditional density of
Y = y given (K = k; L = l;X = x) is formulated through the logistic regression model
P;(yjk; l;x) = expfy( + 
TZ(k; l;x))g
1 + expf + TZ(k; l;x)g ; (4.1)
where Z(k; l;x) is a design vector excluding the unit component. There is considerable
exibility in specifying the disease model. Suppose that there are no environmental
factors. A linear predictor in the form of  + k pertains to an additive eect of the
total copy number and +1I(k = 1)+ : : :+SI(k = S) pertains to a saturated model.
Replacing k with l in the above linear predictors leads to additive and saturated models
of the B allele copy number. Combining k and l, we may specify  + 1(k   l) + 2l
with 1 and 2 corresponding to the A allele and B allele copy numbers, respectively,
or  + 1k + 2f(k   l)   lg with 1 and 2 corresponding to the total copy number
and allelic dierence, respectively.
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Although we are interested in the eects of (K;L;X) on Y , we only observe allele-
specic intensity measurements on the Aymetrix platform and the transformed quan-
tities on the Illumina platform, instead of (K;L). We denote the observed two-
dimensional measurements by R. Thus we have a regression problem with measure-
ment errors. We describe below how to model the measurement error distribution
P (RjY;K;L;X). Note that by modelling the distribution conditional on Y and X,
we allow for the distribution to depend on the disease group and environmental fac-
tors such as indicators of batches. Specic formula of P (RjY;K;L;X) depends on the
platforms.
Aymetrix SNP Data
Each SNP on the Aymetrix platform generates a pair of intensity measurements
(RA; RB) for the A and B alleles, respectively. The two measurements are log2-
transformed values from the normalized raw intensities ( eRA; eRB). We assume that
(RA; RB) given (Y;K;L;X) follows a bivariate Gaussian distribution:
P;(RA; RBjY;K;L;X)
= 
(264RA
RB
375 ;
264TAA
TBB
375 ;
264 g(TAC) TW
q
g(TAC)g(TBD)
TW
q
g(TAC)g(TBD) g(TBD)
375);
where  = (A;B),  = (A; B; ), (r;;) is the bivariate normal density func-
tion with mean  and covariance matrix , A, B, C, D and W stand for A(y; k; l;x),
B(y; k; l;x), C(y; k; l;x), D(y; k; l;x) andW(y; k; l;x), respectively, which are the design
vectors for the means, variances and the correlation coecient, and g(:) is a link func-
tion, such as the exponential function, that constraints the variances to be non-negative.
We may utilize a saturated model for the dependence of (RA; RB) on (Y;K;L;X), so
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each bivariate Gaussian distribution of (RA; RB) given (Y;K;L;X) are completely de-
termined by ve parameters consisting of two means, two variances and a correlation
coecient.
Illumina SNP Data
On the Illumina platform, we obtain the measurements on so-called Log R ratio
and B allele frequency (RLRR; RBAF), which are transformed values of the raw allele-
specic intensities ( eRA; eRB). Let eRT = eRA + eRB and  = arctan( eRA= eRB)=(=2) so
that eRT measures the total copy number and  measures the allelic contrast. Then,
RLRR, a normalized measure of the total signal intensity for each SNP, is calculated
as RLRR = log2( eRT;observed= eRT;expected), where eRT;expected is computed from a linear
interpolation of the canonical genotype clusters corresponding to AA, AB and BB. A
normalized measure of  is calculated as
RBAF =
8>>>>>>>>>><>>>>>>>>>>:
0 if  < AA;
0:5(   AA)=(AB   AA) if AA   < AB;
0:5 + 0:5(   AB)=(BB   AB) if AB   < BB;
1 if   BB;
where AA, AB, and BB are the  values for the three canonical genotype clusters
generated from a large set of reference samples. As a result, RBAF should be around
0, 0.5 and 1 for genotype AA, AB and BB, respectively. If the RBAF value of a SNP
deviates from the three values, it may indicate CNV. For instance, a RBAF value 0.33
may indicate a genotype of AAB.
By their denitions, RLRR andRBAF can be treated as independent given (Y;K;L;X).
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We model the conditional distribution of RLRRj(Y;K;L;X) by a normal density
P;(RLRRjY;K;L;X) = (RLRR;TLRRA(Y;K;X); g(TLRRC(Y;K;X)));
where (r;; 2) is the univariate normal density function with mean  and variance 2,
A(y; k;x) and C(y; k;x) are the design vectors for the mean and variance, respectively,
and g(:) is the link function for the variance. Note that the design vectors do not
depend on L.
We model the distribution of RBAF given (Y;K;L;X) by a (truncated) normal
density,
P;(RBAFjY;K;L;X) = (RBAF;TBAFB; g(TBAFD))I(0<RBAF<1)
 (0;TBAFB; g(TBAFD))I(RBAF=0)


1  (1;TBAFB; g(TBAFD))
I(RBAF=1)
;
where (r;; 2) is the cumulative distribution function corresponding to (r;; 2),
and B, D stand for B(y; k; l;x), D(y; k; l;x), respectively, which are the design vectors
for the mean and variance. Note that  = (LRR;BAF) and  = (LRR; BAF). When
K = 0 indicating deletion of both copies, we assume that the mean of RBAF to be a
constant 0.5 and the variance is smaller than 0.15 so that the probability of truncation
is smaller than 0.001. Therefore as an approximation, we can estimate the variance as
if P;(RBAFjY;K = 0; L;X) is non-truncated normal. When K > 0, we assume the
means to be 0.0 and 1.0 for the two homozygous genotypes, so we only need to estimate
the variances, which is straightforward because the truncation points are exactly the
mean values. Specically, we simply use the observed RBAF such that 0 < RBAF < 1
to estimate the variance. For all the other normal components (which correspond
to heterozygous genotypes), we assume that the mean values are far away from the
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boundary (0 or 1) so that the truncation eects can be neglected.
Write R = (RA; RB) for Aymetrix data and R = (RLRR; RBAF) for Illumina data.
In addition, write k;l = P (K = k; L = l) and  = (0;0; 1;0; 1;1 : : : ; S;S). We suppose
that k;l > 0 for all (k; l). In some applications, X and (K;L) are correlated. One
important example is when X represents the principal components for ancestry. Also,
certain genes may inuence both environmental exposure and disease occurrence, as
is the case in a lung cancer study involving a gene and a smoking variable (Amos
et al., 2008). In such cases, we allow gene-environment dependence by leaving the
distributions of X given (K;L), denoted by Fk;l(:), completely unspecied. Because of
the case-control sampling, we adopt the retrospective likelihood
Lr(; fFk;lg) =
nY
i=1
(
SX
k=0
kX
l=0
P;(RijYi; k; l;Xi) P;(Yijk; l;Xi)fk;l(Xi)k;lP
k0
P
l0
R
x
P;(Yijk0; l0;x)k0;l0dFk0;l0(x)
)
;
where  = (;; ;; ), and n is the number of study subjects. We can see that the
observed data (Ri; Yi;Xi) for subject i is modeled by a mixture of bivariate-Gaussian
clusters. The intensity measurements are used to infer the cluster membership, sepa-
rately within cases and controls at each level of X. The inferred frequencies of each
cluster are compared between cases and controls, and dierences of the frequencies are
attributed to the disease model as association.
Because the distribution of the covariates (K;L;X) is completely unspecied, the
retrospective maximum likelihood estimate of  can be obtained by maximizing the
prospective likelihood,
Lp(; fFk;lg) =
nY
i=1
(
SX
k=0
kX
l=0
P;(RijYi; k; l;Xi)P;(Yijk; l;Xi)fk;l(Xi)k;l
)
; (4.2)
see Roeder et al. (1996) for justication for such equivalence. We use the NPMLE
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approach. In this approach, the distribution functions fFk;lg are treated as right-
continuous functions with jumps at the observed X. The objective function to be
maximized is obtained from Lp(; fFk;lg) by replacing fk;l(x) with the jump size of
Fk;l at x. The maximization can be carried out by the EM algorithm described in the
Appendix.
In many applications, it is appropriate to assume gene-environment independence,
so that fFk;lg reduces to a single distribution function F . In addition, by the HWE
assumption, L = l given K = k follows a binomial distribution with parameters k
and pB, where pB is the population frequency of the B allele. We denote the binomial
distribution by Pk;pB(l) and denote k = P (K = k), so that k;l = Pk;pB(l)k. Let
 = (0; : : : ; S). When we impose such structures in the covariate distribution, the
equivalence between the retrospective and prospective likelihoods no longer holds and
the retrospective likelihood should be used.
There is very little information about  in the retrospective likelihood, so the prob-
lem is virtually nonidentiable. One possible solution is to assume that the disease
is rare, which is generally true in case-control studies. Then we have the following
approximation to (4.1):
P;(yjk; l;x)  expfy( + TZ(k; l;x))g:
Write  = (;; pB;; ). The retrospective likelihood can then be approximated by
eLr(; F )
=
nY
i=1
(
SX
k=0
kX
l=0
P;(RijYi; k; l;Xi) expf
TZ(k; l;Xi)gPk;pB(l)kf(Xi)R
x
P
k0
P
l0 expfTZ(k0; l0;x)gPk0;pB(l0)k0dF (x)
)I(Yi=1)

(
SX
k=0
kX
l=0
P;(RijYi; k; l;Xi)Pk;pB(l)kf(Xi)
)I(Yi=0)
: (4.3)
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We see that  is dropped from the likelihood. We again adopt the NPMLE approach,
which is implemented via the EM algorithm described in the Appendix.
4.2.2 Total Copy Number Measurement
In some cases, such as the copy number probes of Aymetrix 6.0 array and the ar-
ray comparative genomic hybridization (CGH), the observed data only contain mea-
surements of the total copy number. Let Ri be the one-dimensional measurement and
P;(RjY; k;X) be a univariate normal density, which is the same as P;(RLRRjY; k; l;X).
We can easily accommodate such cases by reducing (4.2) and (4.3) to
Lp(; fFkg) =
nY
i=1
(
SX
k=0
P;(RijYi; k;Xi)P;(Yijk;Xi)fk(Xi)k
)
; (4.4)
where  = (;;;; ), and
eLr(; F ) = nY
i=1
(
SX
k=0
P;(RijYi; k;Xi) expfYi
TZ(k;Xi)gkf(Xi)R
x
P
k0 expfYiTZ(k0;Xi)gk0dF (x)
)I(Yi=1)

(
SX
k=0
P;(RijYi; k;Xi)kf(Xi)
)I(Yi=0)
; (4.5)
where  = (;;; ), respectively. Barnes et al. (2008) dealt with this problem by
adopting a simpler prospective likelihood
nY
i=1
(
SX
k=0
P;(RijYi; k;Xi)P;(Yijk;Xi)P(kjXi)
)
; (4.6)
where P(kjx) is the multinomial regression model of K = k given X = x. When there
are no environmental factors, (4.6) is exactly the same as (4.4). Thus, Barnes' method is
justied. In the presence of environmental factors, Barnes et al. (2008) decomposed the
joint density function P (K;X) as P (KjX)P (X) and imposed a parametric structure
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on P (KjX). With the parametric restriction, the use of prospective likelihood is no
longer appropriate.
4.3 Simulation Studies
We conducted extensive simulation studies to evaluate the performance of the proposed
and existing methods in realistic settings. We generated data with the pattern observed
at one SNP site in the GWAS data of schizophrenia (Shi et al., 2009); see Figure 4.1(a).
Specically, we assumed that in the general population the total copy number state K
takes values 0, 1, and 2 with probabilities 0.06, 0.33 and 0.61. GivenK, the B allele copy
number L follows the binomial distribution with probability 0.65. We simulated the
disease status from the logistic regression model logitP (Y = 1jK;L) = +TZ(K;L),
where  =  4:6 yielding disease rate about 1% and Z(K;L) is a specic function
of K and L. We repeated the above processes until we obtained 1,000 controls and
1,000 cases to form the case-control samples. For controls, the intensity measurements
given each (K;L) cluster were normal with the observed means and variances. The
distribution of intensity measurements for cases were allowed to have dierent means
or variances as compared to controls. We obtained 5,000 replicates of the dataset.
Our rst set of simulation studies was designed to explore the sensitivity of the type
I error to the dierences in the cluster mean and variance between cases and controls.
We simulated the disease status from the logistic regression model with an additive
eect of the B allele copy number:
logitP (Y = 1jK;L) =  + 0L: (4.7)
We applied our method as well as two alternative imputation methods that mimic the
existing calling algorithms. Both imputation methods use a two-dimensional GMM
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to assign each individual to the most likely ASCN cluster. While one ts the GMM
with cases and controls combined (imputation-C), the other one with cases and con-
trols separated (imputation-S). As shown in Figure 4.2, imputation-C is robust to
dierential variances between cases and controls in that it does not generate dieren-
tial misclassication. However, this approach breaks down in the presence of location
shifts. Imputation-S is not aected by dierential errors in either means or variances as
cases and controls are modeled separately. However, ination of type I error remains in
all cases. The ination results from ignoring the uncertainty in cluster assignment and
from over-estimating the dierences in cluster frequencies between cases and controls,
as nuisance parameters are allowed to vary between cases and controls. As a result,
the true variance of the estimator of 0 is greater than the naive variance estimator.
Figure 4.2(b) shows that the ination of type I error for imputation-S grows as the
overall variation increases and is independent of dierential variances. By contrast,
the proposed method provides the most robust test by modelling cases and controls
separately and accounting for all uncertainties.
In the second set of simulation studies, we investigated the pitfalls of the imputation
approach more closely. We assumed no dierences in cluster means and variances
between cases and controls in order to separate the inuence of imputation itself from
that of dierential errors; the rest of the simulation set-up was the same as the rst
set of simulation studies. Table 4.1 shows that the coecient estimator of imputation-
C is biased towards the null, which is due to ignoring the phenotype when inferring
the ASCN states so that the imputed ASCN states are more homogeneous between
cases and controls than they actually are. As a result, the power of imputation-C is
diminished compared to the proposed method. Imputation-C yields correct variance
estimator under the null and thus has proper control of type I error; see Hu and Lin
100
(2010) for a proof in the context of SNP association analysis. As expected, imputation-
S is not subject to bias. However, Table 4.1 exhibits large discrepancies between the
true variances of b0 and the naive estimators. The discrepancy remains under the null,
leading to inated type I error. As a result, imputation-S can sometimes be more
powerful than the proposed method.
When only the eect of the total copy number is of interest, Barnes' method can
also be used to account for dierential errors. In this case, our method still relies on the
two-dimensional measurements for ASCN while Barnes' method relies on the summed
measurements for the total copy number. We compared the two methods in the third
set of simulation studies. We generated the disease status from the logistic regression
model
logitP (Y = 1jK) =  + 0K: (4.8)
The results are summarized in Table 4.2. Both methods yield unbiased estimators for
0 and correct variance estimators and consequently correct type I error. However, the
proposed method gains power by exploiting more information; see Figure 4.3.
Our previous simulation studies are based on ASCN intensity data at SNP sites.
It is also of interest to compare the proposed and Barnes' methods when only total
copy number measurements are obtained. Since we theoretically proved that the two
methods are equivalent in the absence of environmental factors, we focused on testing
the gene-environment interaction on the disease in the forth set of studies. We adopted
the disease model
logitP (Y = 1jK;X) =  + 1K + 2X + 3KX;
where X follows the standard normal distribution and is independent of K. We gen-
erated cluster means and variances of the one-dimensional measurements mimicking
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those of CN 615718 in the schizophrenia data; see Figure 4.1(b). As shown in Figure
4.4, the proposed method based on the retrospective likelihood (4.3) is substantially
more powerful than Barnes' method. The power gain of the propose method is largely
attributed to its incorporation of gene-environment independence.
4.4 Schizophrenia Data
Schizophrenia is a severe psychiatric disorder marked by hallucinations, delusions, cog-
nitive decits and apathy, with a lifetime prevalence of 0.4-1%. Schizophrenia has high
heritability ( 80%) and genetically heterogeneous. Recent studies implicated that
common SNPs and rare, large CNVs are associated with schizophrenia, but the joint
eects of CNVs and SNPs have not been investigated. We applied our methods for
integrated analysis of CNVs and SNPs using the data from the Molecular Genetics of
Schizophrenia (MGS) GWAS (Shi et al., 2009). MGS GWAS collected self-reported
European ancestry (EA) and African American (AA) unrelated adult cases with DSM-
IV schizophrenia from ten sites in the United States and Australia, and recruited EA
and AA unrelated adult controls through Knowledge Networks by phone calls. Part of
the MGS GWAS was genotyped with the Aymetrix 6.0 platform at the Broad Insti-
tute, under the auspices of the Genetic Association Information Network (GAIN) and
was referred to as the GAIN samples. The GAIN samples consist of both EA and AA
subjects. Our data is the EA portion, including 1172 cases and 1378 controls. The
dierent collection processes of cases and controls imply the possibility of dierential
errors. Indeed, when we treated all controls as if they were from the 11th site, the prin-
cipal components (PCs) calculated from the raw intensity data were correlated with
many of these eleven site indicators.
For intensity data at SNP sites, our method regresses the disease status on both
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the total copy number and the dierence of the allelic copy number
logitP (Y = 1jK;L) =  + 1K + 2f(K   L)  Lg:
A two-degrees-of-freedom test of the null hypothesis H0 : 1 = 2 = 0 provides a
combined test of CNV and allelic eects; the null hypothesis H0 : 1 = 0 gives a test of
the CNV eect controlling for allelic variation; the null hypothesis H0 : 2 = 0 gives a
test of the allelic eect controlling for copy number variation.
The testing results of the intensity data displayed in Figure 1.1 are shown in Ta-
ble 4.3. As Figure 1.1 suggests serious dierential errors but no appreciable dier-
ences of cluster frequencies between cases and controls, the proposed method yielded
non-signicant p-values for all three tests. As expected, imputation-C is sensitive to
dierential means. Imputation-S is sensitive to cluster variances, especially when the
variances are large so that the clusters are not well-separated.
On the other hand, the intensity data at the SNP site displayed in Figure 4.5 show
little dierential errors but a sign of true association. Consistent with the second set of
simulation results, the proposed method tends to generate a smaller p-value than both
imputation methods (Table 4.4).
For intensity data at copy number probes, we tted the saturated model
logitP (Y = 1jK) =  + 1I(K = 0) + 2I(K = 1):
A two-degrees-of-freedom test of the null hypothesis H0 : 1 = 2 = 0 provides an
overall test of CNV eects. As a comparison, we also included an imputation approach
with CNVs called by PennCNV. Note that PennCNV assumes the intensity means
and variances given a CNV state to be constant, regardless of the disease status. The
intensity data and testing results are presented in Figure 4.6 and Table 4.5, respectively.
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Again, the proposed method is robust to dierential errors and more powerful in the
presence of true association as compared to the imputation method.
104
7 8 9 10
7
8
9
10
(a) SNP_A−2055772
A allele intensity
B 
al
le
le
 in
te
ns
ity
7 8 9 10 11 12
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
1.
2
(b) CN_615718
Total copy number intensity
de
ns
ity
Figure 4.1: Observed intensity measurements in the schizophrenia data. (a) Intensity
measurements at the SNP site \SNP A-2055772". (b) Intensity measurements at the
copy number probe \CN 615718".
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Table 4.1: Simulation results for studying the eect of the B allele copy number when
there are no dierential errors
Proposed Imputation-C Imputation-S
0 Bias SE SEE CP Power Bias SE SEE CP Power Bias SE SEE CP Power
.00 .000 .064 .064 .993 .007 .001 .062 .063 .992 .008 .000 .072 .063 .975 .025
.14 .000 .063 .064 .992 .346 -.004 .062 .063 .992 .335 .000 .072 .063 .976 .384
.18 .001 .065 .064 .989 .599 -.005 .064 .063 .989 .590 .001 .073 .063 .973 .610
.22 .001 .064 .064 .991 .806 -.005 .062 .063 .991 .797 .002 .073 .063 .975 .793
.26 .001 .065 .064 .988 .929 -.007 .063 .063 .988 .925 .000 .073 .063 .976 .912
.30 .001 .065 .064 .990 .981 -.008 .063 .063 .988 .980 .002 .073 .063 .974 .975
.40 .000 .065 .065 .990 .999 -.013 .065 .063 .985 1.00 .000 .075 .064 .972 .999
.80 -.002 .066 .066 .991 1.00 -.027 .067 .067 .983 1.00 .002 .079 .067 .973 1.00
NOTE: Bias and SE are the bias and standard error of the parameter estimator. SEE
is the mean of the standard error estimator. CP is the coverage probability of the
99% condence interval. Power is the type I error/power for testing H0 : 0 = 0 at the
.01 nominal signicance level.
Table 4.2: Simulation results for studying the eect of the total copy number
Proposed Barnes et al.
0 Bias SE SEE CP Power Bias SE SEE CP Power
0.0 -0.002 0.087 0.087 0.991 0.009 -0.001 0.089 0.090 0.989 0.011
0.1 0.000 0.090 0.089 0.990 0.069 0.000 0.091 0.092 0.990 0.065
0.2 0.000 0.091 0.091 0.991 0.351 0.000 0.093 0.094 0.991 0.324
0.3 -0.001 0.095 0.094 0.991 0.738 0.000 0.097 0.096 0.990 0.719
0.4 -0.001 0.096 0.097 0.992 0.945 0.000 0.098 0.099 0.992 0.934
NOTE: see the Note to Table 4.1.
Table 4.3: P-values of hypothesis tests at the SNP site showing dierential errors
1 = 2 = 0 1 = 0 2 = 0
Proposed 9.47e-01 7.51e-01 9.41e-01
Imputation-C 9.35e-12 2.96e-10 1.08e-02
Imputation-S 2.39e-41 4.04e-34 2.88e-07
Table 4.4: P-values of hypothesis tests at the SNP site showing true association
1 = 2 = 0 1 = 0 2 = 0
Proposed 1.65e-02 9.00e-01 4.65e-03
Imputation-C 2.53e-02 1.51e-01 1.47e-02
Imputation-S 9.91e-02 8.24e-01 4.02e-02
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Figure 4.2: Type I error for testing the null eect of the B allele copy number at the
1% nominal signicance level. (a) Type I error is estimated for association methods at
dierent values of dierential shift of means. We let  to be the uniform dierence of
all cluster means between cases and controls. (b) Type I error is shown for association
methods at dierent values of dierential shift in variances. The cluster variances
of cases are inated against those of controls by a factor of 2. Note that when
2 < 1:0, cases have deated cluster variances compared to controls. The green line
indicates the nominal level of 1%.
Table 4.5: P-values of hypothesis tests at the copy number probes
CN 710839 CN 1197999
Proposed 9.80e-01 1.67e-02
Imputation 8.70e-03 3.74e-01
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Figure 4.3: Power for testing the eect of the total copy number.
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Figure 4.4: Power of testing the gene-environment interaction at the 1% nominal sig-
nicant level.
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Figure 4.5: Observed intensity measurements at the SNP site \SNP A-8303785".
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Figure 4.6: PC-summarized intensity data at copy number probes \CN 710839" (left
panel) and \CN 1197999" (right panel).
109
4.5 Appendix
4.5.1 Theoretical Properties
NPMLE of Likelihood (4.2)
We rst impose the following identiability conditions and verity the identiability
of the parameters in Lemma 4.1.
CONDITION 4.1. If  + TZ(K;L;X) = e + eTZ(K;L;X) for any (K;L;X), then
 = e and  = e.
CONDITION 4.2. If P;(RjY;K;L;X) = Pe;e(RjY;K;L;X) for any (R; Y;K; L;X),
then  = e and  = e.
LEMMA 4.1. If two sets of parameters (; fFk;lg) and (e; f eFk;lg) yield the same
likelihood, then  = e and Fk;l = eFk;l for all (k; l).
Proof: Suppose that
SX
k=0
kX
l=0
P;(RjY; k; l;X)P;(Y jk; l;X)fk;l(X)k;l
=
SX
k=0
kX
l=0
Pe;e(RjY; k; l;X)Pe;e(Y jk; l;X) efk;l(X)ek;l:
By Proposition 1 of Teicher (1963) that all nite mixtures of normal distributions is
identiable and Condition 4.2,  = e,  = e, and for all (k; l),
P;(Y jk; l;X)fk;l(X)k;l = Pe;e(Y jk; l;X) efk;l(X)ek;l:
Summarizing over Y = 0; 1 yields fk;l(X)k;l = efk;l(X)ek;l. In addition, integrating
over X gives k;l = ek;l and then fk;l(:) = efk;l(:) for any (k; l). Thus, P;(Y jk; l;X) =
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Pe;e(Y jk; l;X). It then follows from that P;(Y jk; l;X) is logistic regression model
and from Condition 4.1,  = e and  = e.
We then verify that the information matrices along all non-trivial parametric sub-
models are non-singular in LEMMA 4.2.
CONDITION 4.3. If there exists a constant  such that Tr; logP;(Y jk; l;X) = 0
for any (k; l), then  = 0.
CONDITION 4.4. For any (k; l), the function fk;l is positive its support and continu-
ously dierentiable.
LEMMA 4.2. If there exist a vector  = (;;; ;) and functions  k;l(x)
with E[ k;l(X)] = 0 such that
T l(0; F0) +
X
k;l
lFk;l(0; Fk;l;0)[
Z
 k;l dFk;l;0] = 0; (4.9)
where l is the score function for , and lFk;l [
R
 k;l dFk;l;0] is the score function for Fk;l
along the submodel Fk;l;0 + 
R
 k;l dFk;l;0, then  = 0 and  k;l = 0 for any (k; l).
Proof: For ease of exposition, we derive the proof based on the likelihood (4.4) with
univariate normal densities. A similar equation to (4.9) is expanded as
X
k
P;(RjY; k;X)
(
P;(Y jk;X)fk(X)k
"
(R  TA)
exp TC 
T
A 
1
2
 
1 (R  
TA)2
exp TC

T C
#
+ T;r;P;(Y jk;X)fk(X)k + P;(Y jk;X)fk(X)Trk
+ P;(Y jk;X)fk(X) k(X)k
)
= 0;
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which is essentially
SX
k=0
exp

 (R  k)
2
22k

(akR
2 + bkR + ck) = 0; (4.10)
where k = 
TA(Y; k;X) and 2k = exp TC(Y; k;X). Let k = exp
 (R   k)2=22k	
and reorder the component 0; : : : ; S lexicographically by: k  k0 if k > k0 or if
k = k0 but k > k0 . Denote the ordered k as (~0; : : : ;  ~S). Dividing (4.10) by ~0,
we have
a~0R
2 + b~0R + c~0 =  
~SX
k=~1
exp

 (R  k)
2
22k
+
(R  ~0)2
22~0

(akR
2 + bkR + ck):
Each exponential component on the right hand side will be of the order either exp( R2)
or exp( R), so the right hand side will go to zero as R!1. On the contrary, the left
hand side will go away from 0 if a~0 and b~0 are not 0. Thus a~0 = 0, b~0 = 0 and c~0 = 0.
Next, divide the remains of (4.10) by ~1. By the same argument, a~1 = 0, b~1 = 0 and
c~1 = 0. Iterate until ak, bk and ck are 0 for all k, which implies ; = 0 and for any k,
T;r;P;(Y jk;X)fk(X)k + P;(Y jk;X)fk(X)Trk
+ P;(Y jk;X)fk(X) k(X)k = 0:
Summarizing over Y = 0; 1 and applying Condition 4.4 yields Trk+ k(X)k = 0:
Further, taking expectation over X gives  = 0 and hence  k = 0. Thus,
T;r;P;(Y jk;X)fk(X)k = 0, for any k. By Condition 4.3 and 4.4, ; = 0.
We state the asymptotic results in Theorem 4.1.
THEOREM 4.1. Assume that Conditions 4.1-4.4 hold. Then jb 0j+supx;k;l jdFk;l(x) 
Fk;l;0(x)j ! 0 almost surely, and n1=2(b   0) converges in distribution to a zero-mean
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normal random vector whose covariance matrix attains the semiparametric eciency
bound.
NPMLE of Likelihood (4.3)
We rst verity the identiability of the parameters in Lemma 4.3.
LEMMA 4.3. If two sets of parameters (; F ) and (e; eF ) yield the same likelihood,
then  = e and F = eF .
Proof: Suppose that
(
SX
k=0
kX
l=0
P;(RjY; k; l;X) expf
TZ(k; l;X)gPk;pB(l)kf(X)R
x
P
k0
P
l0 expfTZ(k0; l0;x)gPk0;pB(l0)k0dF (x)
)I(Y=1)

(
SX
k=0
kX
l=0
P;(RjY; k; l;X)Pk;pB(l)kf(X)
)I(Y=0)
=
(
SX
k=0
kX
l=0
Pe;e(RjY; k; l;X) expf
eTZ(k; l;X)gPk;epB(l)ek ef(X)R
x
P
k0
P
l0 expfeTZ(k0; l0;x)gPk0;epB(l0)ek0d eF (x)
)I(Y=1)

(
SX
k=0
kX
l=0
Pe;e(RjY; k; l;X)Pk;epB(l)ek ef(X)
)I(Y=0)
: (4.11)
Letting Y = 0 in (4.11), we obtain
SX
k=0
kX
l=0
P;(RjY; k; l;X)Pk;pB(l)kf(X) =
SX
k=0
kX
l=0
Pe;e(RjY; k; l;X)Pk;epB(l)ek ef(X):
By Proposition 1 of Teicher (1963) and Condition 4.2,  = e,  = e, and
Pk;pB(l)kf(X) = Pk;epB(l)ek ef(X);
for any (k; l). Summarizing over l gives kf(X) = ek ef(X). Further, summarizing over
k yields f(:) = ef(:) and then k = ek for any k. Thus, Pk;pB(l) = Pk;epB(l), implying
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pB = epB. Letting Y = 1 in (4.11) and applying Proposition 1 of Teicher (1963) again,
we see that for any (k; l),
expfTZ(k; l;X)gR
x
P
k0
P
l0 expfTZ(k0; l0;x)gPk0;pB(l0)k0dF (x)
=
expfeTZ(k; l;X)gR
x
P
k0
P
l0 expfeTZ(k0; l0;x)gPk0;epB(l0)ek0d eF (x) :
It then follows from Condition 4.1 that  = e.
We then verify that the information matrices along all non-trivial parametric sub-
models are non-singular in LEMMA 4.4.
LEMMA 4.4. If there exist a vector  = (;; pB ; ;) and functions  (x)
with E[ (X)] = 0 such that
T l(0; F0) + lF (0; F0)[
Z
 dF0] = 0; (4.12)
where l is the score function for , and lF [
R
 dF0] is the score function for F along
the submodel F0 + 
R
 dF0, then  = 0 and  = 0.
Proof: We rst set Y = 0 in (4.12), which then becomes
X
k;l
P;(RjY; k; l;X)
(
T;r; logP;(RjY; k; l;X)Pk;pB(l)k
+ T;pBr;pBPk;pB(l)k + Pk;pB(l)k (X)
)
= 0:
By the same argument in the proof of Lemma 4.2, ; = 0 and for any (k; l),
T;pBr;pBPk;pB(l)k + Pk;pB(l)k (X) = 0:
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Summarizing over l yields  = 0 and then ;pB = 0.
Letting Y = 1 in (4.12), we have
X
k;l
P;(RjY; k; l;X)eTZ(k;l;X)Pk;pB(l)k

(
TZ(k; l;X) 
R
x
P
k0
P
l0 e
TZ(k0;l0;x)TZ(k0; l0;X)Pk0;pB(l0)k0dF (x)R
x
P
k0
P
l0 e
TZ(k0;l0;x)Pk0;pB(l0)k0dF (x)
)
= 0:
Applying Proposition 1 of Teicher (1963) yields TZ(k; l;X) being a constant for all
(k; l). By Condition 4.1, T = 0.
We impose the following regularity conditions, and then state the asymptotic results
in Theorem 4.2.
CONDITION 4.5. The fraction n1=n! % 2 (0; 1):
CONDITION 4.6. The function f is positive in its support and continuously dieren-
tiable.
CONDITION 4.7. For i = 1; : : : ; n, the conditional distribution of Yi given (Ki; Li;Xi)
satises that
P (YijKi; Li;Xi) = an expfT0Z(Ki; Li;Xi)g=[1 + an expfT0Z(Ki; Li;Xi)g];
where an = o(n
 1=2).
THEOREM 4.2. Assume that Conditions 4.1-4.2,4.5-4.7 hold. Then jb 0j+supx j bF (x) 
F0(x)j ! 0 almost surely, and n1=2(b   0) converges in distribution to a zero-mean
normal random vector whose covariance matrix attains the semiparametric eciency
bound.
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Proof: The proof follows the arguments in the proofs of Theorem S.1 and S.2 in Hu
et al. (2010).
4.5.2 Numerical Algorithms
EM Algorithm to maximize (4.2)
Suppose that there are Jk;l distinct values of X given (K = k; L = l), denoted by
xk;l;1; : : : ;xk;l;Jk;l . Let k;l;j be the jump size of Fk;l at xk;l;j. Note that
PJk;l
j=1 k;l;j = 1.
The complete-data score function is
nX
i=1
SX
k=0
kX
l=0
Jk;lX
j=1
I(Ki = k; Li = l;Xi = xk;l;j)
(
logP;(RijYi; k; l;Xi)
+ logP;(Yijk; l;Xi) + log k;l;j + log k;l
)
:
In the E-step, we evaluate EfI(Ki = k; Li = l;Xi = xk;l;j)jRi; Yi;Xig, which can be
shown to be
!iklj  I(Xi = xk;l;j)P;(RijYi; k; l;Xi)P;(Yijk; l;Xi)k;l;jk;lP
k0;l0 P;(RijYi; k0; l0;Xi)P;(Yijk0; l0;Xi)k0;l0;jk0;l0
:
In the M-step we use the one-step Newton-Raphson iteration to update the parameter
estimates based on rst and second derivatives derived from the complete-data score
function with I(Ki = k; Li = l;Xi = xk;l;j) replaced by !iklj. Note that the update of
k;l;j is subject to
PJk;l
j=1 k;l;j = 1 for any (k; l) and all k;l;js are nonnegative. Similarly,
k;l is subject to
P
k;l k;l = 1 and all k;ls are nonnegative. These constraints can be
incorporated by transforming the parameters to yk;l;j = log(k;l;j=k;l;1), where j =
2; : : : ; Jk;l and 
y
k;l = log(k;l=0;0), where (k; l) 6= (0; 0). The initial values of the
parameters are set as follows. We set , , yk;l;j and 
y
k;l all to 0. We let (; )
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take the empirical means and variances of the clusters classied by any CNV calling
method. For example, Birdsuite can directly call allele-specic copy numbers. Starting
with such initial values, we iterate between the E-step and M-step until the change of
logLp(; fFk;lg) is negligible.
We can estimate the limiting covariance matrix of b and bFk;l by inverting the
(observed-data) information matrix for all the parameters including the jump sizes
of bFk;l. The information matrix is obtained via the Louis (1982) formula. We can also
estimate the limiting covariance matrix of b by using the prole likelihood function
pln()  maxfFk;lg logLp(; fFk;lg). Particularly, the (s; t)th element of the inverse co-
variance matrix of b can be estimated by   2n npln(b + nes + net)  pln(b + nes) 
pln(b + net) + pln(b)o, where n is a constant of order n 1=2, and es, and et are the
sth and tth canonical vectors. We calculate pln() via the EM algorithm by holding 
constant in both the E-step and M-step.
Prole Likelihood of (4.3)
Suppose that there are J distinct values of X, denoted by x1; : : : ;xJ . Let n+j be
the number of times that xj is observed in the data and let j be the jump size of
F at xj. Note that
PJ
j=1 j = 1. Before we use EM algorithm, we rst show that
 = (1; : : : ; J)
T can be proled out by introducing one free parameter. The log-
likelihood is
eln(;) = nX
i=1
log
(X
k;l
P;(RijYi; k; l;Xi) expfYiTZ(k; l;Xi)gPk;pB(l)k
)
+
JX
j=1
n+j log j   n1 log
nX
j0
X
k0;l0
expfTZ(k0; l0;xj0)gPk0;pB(l0)k0j0
o
:
We introduce a Lagrange multiplier  for the constraint
PJ
j=1 j = 1 and set the
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derivative with respect to j to 0. We then obtain
n+j
j
  n1
P
k;l expfTZ(k; l;xj)gPk;pB(l)kP
j
P
k;l expfTZ(k; l;xj)gPk;pB(l)kj
+  = 0:
Multiplying both sides by j and summing over j = 1; : : : ; J , we see that  = n1   n.
Thus
j =
n+j
n0 + n1
P
k;l expfTZ(k; l;xj)gPk;pB(l)k=
;
where  =
P
j
P
k;l expfTZ(k; l;xj)gPk;pB(l)kj. Plugging j back into el(;), we
see the objective function to be maximized is,
ln(; ) =
nX
i=1
log
(X
k;l
P;(RijYi; k; l;Xi) expfTZ(k; l;Xi)gPk;pB(l)k
)
  n+j log
n
1 +
n1
n0
X
k;l
expfTZ(k; l;xj)gPk;pB(l)k
o
  n1 log :
Suppose that the conditional distribution of (R; Y ) given X is characterized by
P (R; Y jX) = P;(RjY; k; l;X) expf
TZ(k; l;X; Y )gPk;pB(l)kP
y=0;1
P
k0;l0 expfTZ(k0; l0;X; y)gPk0;pB(l0)k0
;
where
 =
264log(n1=(n0))

375 ;Z(k; l;x; y) =
264 y
yA(k; l;x)
375 :
We can show that ln(; ) is equivalent to the log-likelihood
ln(#) =
nX
i=1
log
(X
k;l
P;(RijYi; k; l;Xi) expf
TZ(k; l;Xi; Yi)gPk;pB(l)kP
y=0;1
P
k0;l0 expfTZ(k0; l0;Xi; y)gPk0;pB(l0)k0
)
;
where # = (;; pB;; ). We maximize ln(#) through the EM algorithm, in which
(K;L) is treated as missing. The estimation of the covariance matrix of b# is based on
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the information matrix of ln(#).
EM Algorithm to maximize (4.3)
The complete-data score function is
nX
i=1
SX
k=0
kX
l=0
I(Ki = k; Li = l)
(
logP;(RijYi; k; l;Xi)
+ log
expfTZ(k; l;Xi; Yi)gPk;pB(l)kP
y=0;1
P
k0;l0 expfTZ(k0; l0;Xi; y)gPk0;pB(l0)k0
)
:
In the E-step, we evaluate EfI(K = k; L = l)jR; Y;Xg, which can be shown to be
!ikl  P;(RijYi; k; l;Xi) expf
TZ(k; l;Xi; Yi)gPk;pB(l)kP
k0;l0 P;(RijYi; k0; l0;Xi) expfTZ(k0; l0;Xi; Yi)gPk0;pB(l0)k0
:
In the M-step we use the one-step Newton-Raphson iteration to update the parameter
estimates based on rst and second derivatives derived from the complete-data score
function with I(Ki = k; Li = l) replaced by !ikl. The initial values of the parameters
are set as follows. We set  = 0 and  = (1=(1+S); : : : ; 1=(1+S)). We let pB take the
pfb (population frequency of B allele) values in the annotation le of the platform. We
let (; ) take the empirical means and variances of the clusters classied by any CNV
calling method, for example, Birdsuite, which directly calls allele-specic copy numbers.
Starting with such initial values, we iterate between the E-step and M-step until the
change in ln(#) is negligible. Finally, the information matrix of l

n(#) is obtained via
the Louis (1982) formula.
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Chapter 5
Ongoing and Future Research
5.1 Analysis of Untyped SNPs: Tagging-Based and HMM-
Based Methods
5.1.1 Introduction
In Chapel 3, we compared maximum likelihood and imputation methods in analysis of
untyped SNPs, both based on tag SNPs. In this chapter, we compare tagging-based
and HMM-based methods in the analysis of untyped SNPs. Specically, we consider
four methods: 1) the expected genotype count (dosage) imputed by tag SNPs (e.g.,
tagIMPUTE of Hu and Lin, 2010); 2) the expected genotype count imputed by all
SNPs in LD with the untyped SNP (e.g., beagle of Browning and Browning, 2007,
2009); 3) maximum likelihood methods based on tag SNPs (SNPMStat of Lin et al.,
2008, Hu and Lin, 2010); 4) a new quasi-maximum likelihood approach to incorporate
posterior probabilities of genotypes at untyped SNPs generated by any imputation
methods (in particular, HMM-based methods) and to account for the uncertainty in
inferring the posterior probabilities. We establish the theoretical properties of the
proposed quasi-maximum likelihood method and conduct extensive simulation studies,
based on a whole-genome simulation program that mimics the LD patterns in human
populations, to evaluate the performance of the four methods in testing/estimating
genetic eects and gene-environment interactions. We apply the four methods to the
GWAS data from the WTCCC (Burton et al., 2007).
5.1.2 Methods
We propose a new method to analyze the imputed posterior probabilities of genotypes
at untyped SNPs while properly accounting for the imputation uncertainty. We let Gt
denote all genotyped SNPs on the chromosome and let Gu denote the untyped SNP of
interest. Write G = (Gt; Gu). As usual, let Y denote the phenotype of interest, which
can be quantitative or qualitative, and X denote a set of environmental factors. The
joint density of the observed data (Y;X; Gt) can be decomposed as
P (Y;X; Gt) =
X
g=0;1;2
P (Y jX; Gt; Gu = g)P (XjGt; Gu = g)P (Gu = gjGt)P (Gt):
For analyzing the marginal eect of the untyped SNP, P (Y jX; Gt; Gu) reduces to
P (Y jX; Gu). In addition, we assume that the genetic factors are independent of the
environmental factors, so that P (XjGt; Gu) = P (X), which is modelled nonparamet-
ricly with distribution function F (:). We can obtain an estimate of P (GujGt) from any
imputation method, such as beagle or tagIMPUTE. In the presence of a large number of
SNPs in Gt, we can neither estimate P (Gt) nor obtain it from any imputation method,
as it is close to zero for every possible value. Fortunately, we can avoid estimating
P (Gt) as shown below.
Parameter Estimation
We propose to estimate the parameters by maximizing the objective functions derived
below. These objective functions are based on likelihoods for dierent study designs,
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but not themselves proper likelihoods because of the use of the reference sample. Thus
we adopt the term \quasi-maximum likelihood estimator (qMLE)" for the method.
In a cross-sectional study, we measureX andG on n study subjects. We characterize
the association between Y and (X; Gu) by the conditional density P;;(Y jX; Gu),
where ,, and  denote the intercept(s), regression eects and the nuisance parameters
(variance and overdispersion parameters), respectively. The prospective likelihood takes
the form
Ln(;; ) =
nY
i=1
X
g=0;1;2
P;;(YijXi; Gu = g)P (Gu = gjGOi)P (GOi)
/
nY
i=1
X
g=0;1;2
P;;(YijXi; Gu = g)P (Gu = gjGOi):
Denoting ci;g as the estimate of P (Gu = gjGOi), g = 0; 1; 2, for the ith subject, gener-
ated from the previous stage of imputation, the objective function to be maximized is,
after plugging in ci;Gu ,
~Ln(;; ) =
nY
i=1
X
g=0;1;2
P;;(YijXi; Gu = g)ci;g:
In a case-control study, we measure X and G on n1 cases (Y = 1) and n0 controls
(Y = 0). It is natural to formulate the eects of X and Gu on Y through the logistic
regression model
P;(Y jX; Gu) = e
Y (+TZ(X;Gu))
1 + e+
TZ(X;Gu) ;
where  is an intercept,  is a set of log odds ratios, and Z(X; Gu) is a vector-function of
X andGu under a particular mode of inheritance. We make the rare disease assumption,
so P;(Y jX; Gu)  eY (+TZ(X;Gu)). To reect the case-control sampling, we adopt the
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retrospective likelihood
Ln(; F ) =
nY
i=1
P
g=0;1;2 exp

Yi
TZ(Xi; g)
	
F (Xi)P (Gu = gjGOi)P (GOi)R
x
P
Gt;g
exp

Yi
TZ(x; g)	P (Gt; Gu = g)dF (x)
=
nY
i=1
P
g exp

Yi
TZ(Xi; g)
	
F (Xi)P (Gu = gjGOi)P (GOi)R
x
P
g exp

Yi
TZ(x; g)	P (Gu = g)dF (x)
We further let mg, g = 0; 1; 2, denote the estimates of the marginal distributions of the
untyped SNP, i.e., mg = P (Gu = g). Assuming that the study and reference sample
are from the same population, we obtain mg as
n0
n0 + enbpC(Gu = g) + enn0 + enbpR(Gu = g);
where n0 is the number of controls, en is the number of founders in the reference panel
(if it consists of trios), bpR(Gu = g) is simply the empirical frequency of genotype g at
the untyped SNP in the reference sample, and bpC(Gu = g) =Pn0i=1 ci;g. The estimatorbpC(Gu = g) of the marginal distribution of Gu in the control sample results from the
fact that P (Gu = g) = EGtP (Gu = gjGt), which can be approximated by
Pn0
i=1 ci;g.
Plugging in ci;g and mg, the objective function to be maximized is
~Ln(; F ) =
nY
i=1
P
g=0;1;2 exp

Yi
TZ(Xi; g)
	
F (Xi)ci;gR
x
P
g exp

Yi
TZ(x; g)	mgdF (x) :
Note that ~Ln(; F ) involves innite-dimensional parameters if X have continuous com-
ponents. By proling out F (X), the MLE of  can be equivalently obtained by maxi-
mizing
Ln(; ~) =
nY
i=1
P
g=0;1;2 e
Yif~+TZ(Xi;g)gci;gP
y=0;1
P
g e
yf~+TZ(Xi;g)gmg
;
where ~ is a free parameter. When there are no environmental factors, the objective
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function is based on the retrospective likelihood
~Ln() =
nY
i=1
P
g=0;1;2 e
Yi
TZ(Gu)ci;gP
g e
Yi
TZ(g)mg
:
Variance Estimation Accounting for Imputation Uncertainty
We denote all relevant parameters in the objective functions by . The usual variance
estimatior for  based on the inverse the negative second derivatives of the correspond-
ing objective functions does not account for the imputation variation induced by ci;g
and mg. We can incorporate the uncertainty by bootstrapping the samples from which
ci;g and mg are derived. While ci;g solely relies on the reference samples, mg depends on
both the study and reference samples. Thus we bootstrap all samples B times, where
B is set to be 20 here. For each bootstrap, we obtain a new set of ci;g and mg, plug into
the objective functions which is always constructed from the original study samples,
and obtain the estimator bb, b = 1; : : : ; B. Finally, denoting  = B 1PBb=1 bb as the
parameter estimation averaging over the bootstraps, the variance for  is estimated to
be
1
B
BX
b=1
dVar(bb) + B + 1
B
 1
B   1
BX
b=1
(bb   )2;
where dVar(bb) is obtained by inverting the negative second derivatives of the objective
functions at the bth bootstrap.
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5.1.3 Future Work
We will establish the theoretical properties of the proposed quasi-maximum likelihood
method. We will conduct extensive simulation studies, based on a whole-genome sim-
ulation program that mimics the LD patterns in human populations (e.g., GWAsim-
ulator of Li and Li, 2008), to evaluate the performance of the four methods in test-
ing/estimating genetic eects and gene-environment interactions. Specically, we will
explore the extent of the LD information loss due to the restricted number of tag SNPs.
To this end, we will compare tagIMPUTE and beagle in terms of the imputation ac-
curacy and the power of association testing using their imputed dosages. We will also
compare the power of beagle-based imputation, MLE and qMLE. We will apply all of
these methods to the GWAS data from the WTCCC.
5.2 Association Analysis of Allele-Specic Copy Numbers Us-
ing Sequence Data
Figure 5.1 shows that the next-generation sequencing data and SNP array data are
highly similar in term of measuring the total copy number. In Chapter 4, we modeled
the intensity data from the SNP array by a mixture of normal distributions. We plan
to model the number of sequence reads from one window by a Poisson or negative
binomial distribution. There are existing score tests to decide whether there is over-
dispersion in the Poisson model. If there is over-dispersion, we choose a negative
binomial distribution.
One aspect of information missing from Figure 5.1 is the measurement of the ASCN.
The measurements of ASCNs using sequencing data do not readily t into the model
for SNP array data, so we are currently working on appropriate modeling of ASCN
measurements by sequencing data.
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Figure 4 Copy number. Comparison of copy number plots for chromosome
Figure 5.1: Comparison of copy number plots for chromosome 11 of NCI-H2171 be-
tween massively parallel paired-end sequencing and Aymetrix SNP6 genomic array
data (Campbell et al., 2008). In the upper panel of the sequencing data, each point
represents the number of mappable sequence reads in a sliding window of 15kb, which
is transformed to the scale of copy number. In the lower panel of the array data, each
point represents the uorescent intensity measurement at a SNP site or a copy number
probe.
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